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"But Mr Dent, the plans have been available in the local planning office for the last nine 
months." 
"Oh yes, well as soon as I heard I went straight round to see them, yesterday afternoon. You 
hadn't exactly gone out of your way to call attention to them, had you? I mean, like actually tell-
ing anybody or anything." 
[…] 
"But look, you found the notice didn't you?" 
"Yes," said Arthur, "yes I did. It was on display in the bottom of a locked filing cabinet stuck in a 
disused lavatory with a sign on the door saying 'Beware of the Leopard'." Ever thought of going 
into advertising? 
- Douglas Adams, The Hitch-Hiker's Guide to the Galaxy 
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Introduction 
 
This thesis focuses on the evolution and framing of xenotransplantation (XTP) policy debate in 
New Zealand from 1998 to 2011. Its aim is providing a better understanding of both the 
science-society interface and the importance of issue framing policy debate in understanding 
of the scientific debate in New Zealand and its relationship with the public. A qualitative study, 
this thesis draws upon a variety of public science commentary and debate and poses the 
research question: How did xenotransplantation’s introduction and explanation to the New 
Zealand public inform its current status as a Restricted Procedure under New Zealand law; and 
what ethical implications arise from this public policy debate for public participation in bio-
medical research in New Zealand? 
Chapter 1 explains the significance of framing in biomedical public policy discussions as 
seen through the lens of the xenotransplantation debate in New Zealand. This involves a brief 
examination of xenotransplantation in New Zealand, the regulatory response observed from 
1998-2013, and how frame theory can be used to illuminate public policy debate. 
Chapter 2 examines relevant literature on xenotransplantation and public engagement. The 
chapter begins by describing how smaller nations have engaged with biomedical research and 
how cultural variance has informed this process. Then, how the human element within this 
public policy discussion can introduce factors such research or audience bias and that this 
undermines the results of discussion, and ultimately what significance can be attached to 
public engagement programmes. 
Chapter 3 is titled Xenotransplantation: History and Context. While this thesis is exploring 
public engagement of science in New Zealand, the case study being used is 
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xenotransplantation. This chapter then will give the reader essential history and context to a 
relatively obscure medical procedure and the ethical considerations that have arisen from its 
actual and potential usage. 
This is followed by Methodology in Chapter 4; outlining the methods used within and 
examining frame analysis as a method for examining public discourse and how it has been 
applied to the xenotransplantation discussion within New Zealand. 
Chapter 5 is Presentation and Data Analysis. This chapter presents the observed data and 
explains the context to specific frame salience, decline or other notable incidences such as 
event specific frames. 
Chapter 6 is the Discussion chapter. It will consider how factors such as key stakeholders 
and public cultural perceptions influenced discussion on xenotransplantation in New Zealand, 
but also the discussion itself. This chapter will take a broader look at the debate than what is 
seen in Chapter 5 by arguing that the result of the salient frames produces a meta-framed 
cost/benefit analysis. This process and it implication for the public engagement of science in 
this country will be explored and critiqued. 
Chapter 7 includes conclusions and final remarks. This will provide a summary explanation 
of the thesis and its results. It will discuss the current state of xenotransplantation in New 
Zealand, the key stakeholders and a reflection on this thesis, its approach to this issue and 
areas for future research.   
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Chapter One – XTP and Framing 
 
Xenotransplantation is the transplantation of living animal organs, tissue or cells into the 
human body.1 The word, xenotransplantation, has its origins in the Greek word ‘xenos’ - 
meaning foreign; and it is this foreign nature that is central to the biological and societal issues 
with this procedure. The central drive for using xenotransplantation (XTP) is the shortage of 
usable tissue or organs for transplant, though recently, cellular xenotransplantation has been 
promoted as a cure or relief from chronic conditions and degenerative diseases. 
In October 2009, Living Cell Technologies© (LCT) performed a xenotransplantation 
procedure in New Zealand by successfully injecting porcine pancreatic cells into Type One 
diabetics with the expectation that the need for insulin injections would be substantially 
reduced, and with time, eventually eliminated. 
It had been eleven years since the New Zealand Government had imposed restrictions on 
clinical trials of XTP as a measure for public safety. This measure was designed to give the New 
Zealand Government time to evaluate and legislate for what was effectively, an unregulated 
risk - while discussing cultural and spiritual concerns with the New Zealand public. How the 
issue was framed to New Zealanders is significant because of how controversial policy is 
debated in the public arena informs notions of public trust, informed consent and basic 
democratic principles. 
This study argues that debate framing assigns authority and rationalises certain policy 
solutions, while minimising other points of view. This allows for support to be mobilised while 
                                                             
1 Toi te Taiao: the Bioethics Council, The Cultural, Spiritual and Ethical Aspects of Xenotransplantation: Animal-to-
Human Transplantation, A discussion document, January 2005, Ref. BC 11, Bioethics Council website harvest, 
mefe.govt.nz 
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reducing concerns in large sectors of New Zealand society not frequently engaged in the 
political process. The research will show public debate was rationalised down avenues of 
conversation that rarely engaged with issues outside of xenotransplantation’s uncertain risk of 
infection; and because of this, substantive policy debate was effectively reduced to be along 
lines which scientific opinion and business interests had outlined. This meant that authority in 
discussing XTP ultimately rested with key scientific viewpoints held by stakeholders. 
This has large implications regarding how controversial science policy is marketed to the 
general public, ethnic minorities, social movements and organisations. Both inside and outside 
New Zealand, public policy debate takes place regarding the advancement of biomedical 
technologies, such as genetic testing or modification; yet, public input to policy discussion is 
often relegated to an individual’s emotional response, personal story or cultural 
interpretations that are set apart from industry or government viewpoints or analysis 
presented as fact. 
These are important considerations as XTP is an emerging technology that presents issues 
with respect to animal transgenics, the expansion of the biotechnology sector and a worldwide 
tissue shortage that will expanded on in the next section. As Chapter 2 will include literature 
that argues the public is able to participate actively in these discussions and able to critique 
processes that frequently presents scientific information to the public without context and 
evidence. These are considered essential in scientific and academic arenas and show how the 
separation of expert and lay discourse undermines the significance of public engagement with 
science. For this reason such public involvement is indicative of public consultation more so 
than participation.      
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Context 
 
The success of human organ transplant surgery has increased the life expectancy, and 
benefited the lifestyles, of those with previously life-threatening illness. However, this now 
routine procedure called allotransplantation has become a victim of its own success; where 
organ donation falls short of the need for organs, tissue and cells.  Solutions such as XTP have 
been sought to provide a new source of these materials for the ever growing need as life 
expectancy grows as well as aging populations in many developed countries. 
As of late 2014 there are over 123,000 people waiting for organs in the United States of 
America and many of those will require more than one transplant.2 In New Zealand there were 
more than 400 people waiting for organ donation at the end of 2011, while the number of 
deceased organ donors for that year number 38.3 Donors per million of population are 16.4 in 
the UK, 13.5 in Australia, in New Zealand 8.7.4 Even Spain, with its notary presumed consent for 
organ donation, experiences significant bottlenecks of supply and demand.5 
Xenotransplantation may also aid in solutions to degenerative illnesses associated with an 
aging population - such as Parkinson’s disease or Alzheimer’s, by providing alternative cell and 
tissue sources. XTP of organ transplants has not succeeded in the long term because of issues 
that include, but are not limited to: preventing hyper acute rejection, preventing acute 
vascular rejection, facilitating immune accommodation, inducing immune tolerance and 
                                                             
2 U.S. Department of Health and Human Services, Organ Procurement and Transplantation Network, URL: 
http://optn.transplant.hrsa.gov/converge/data/ 
3 Organ Donation New Zealand, Waiting List Times, URL: http://www.donor.co.nz/index.php/about-
transplants/waiting-list-times 
4 Organ Donation New Zealand, ODNZ Annual Report 2013, URL: 
http://www.donor.co.nz/files/Annual_Report_FINAL_2013_online.pdf 
5 Gil-Diaz, Carlos, Spain's Record Organ Donations: Mining Moral Conviction, Cambridge Quarterly of Healthcare 
Ethics (2009), 18: Cambridge University Press, DOI: 10.1017/S0963180109090410, p.257 
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preventing the transmission of viruses from xenografts into humans - otherwise known as 
xenosis or zoonosis.6 
With a worldwide aging population, the issue of organ shortage will only continue to get 
progressively worse. Xenotransplantation has shown limited but significant success - such as 
the 1964 transplant of a chimpanzee kidney in a school teacher, who survived nine months 
before dying of an acute imbalance of electrolytes.7 This is compared to the allotransplantation 
of a heart incurring a 90% survival rate after three years, 70% survival rate of five years and 
half living ten years or more with a donor heart.89 More recently, xenogeneic liver perfusion 
has been used successfully as a bridging technique where the xenograft is attached outside the 
body until a human organ is available.10 
There also has been proven success in the transplant of cells despite concerns of immune 
accommodation, but perhaps the most significant concern with XTP can be described in 
general terms as xenosis. Xenosis is the transference of viral, bacterial or any other type of 
infection passed from the source animal to human. Some of the most famous examples include 
the HIV virus - that mutated from chimpanzees’ Simian Immunodeficiency Virus (SIV), likely 
passed to humans through bush-meat cultivation, and the H1N1/09 influenza more widely 
known as ‘Swine Flu’ since its 2009 pandemic. In the context of XTP a known virus should not 
                                                             
 6 Samdani, Tushar, Xenotransplantation: Overview, MedScape, URL: http://emedicine.medscape.com/article/432418-
overview 
7 Deschamps J.Y., Roux F.A., Sai P., Gouin E l., History of Xenotransplantation, Xenotransplantation, Blackwell 
Munksgaard, 2005, p.90-95 
 8 University of Michigan Cardiac Surgery website, Heart Transplant - Overview, University of Michigan Health 
System, URL: http://med.umich.edu/cardiac-surgery/patient/adult/adultcandt/heart_transplant.shtml 
 9 MedlinePlus Medical Encyclopaedia, Heart transplant, National Library of Medicine - National Institutes of 
Health. URL: http://www.nlm.nih.gov/medlineplus/ency/article/003003.htm 
 10 Deschamps J.Y., Roux F.A., Sai P., Gouin E l., History of Xenotransplantation, Xenotransplantation, Blackwell 
Munksgaard, 2005, p.90-95 
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provide a significant risk to xenografts recipients in light of screenings and appropriate 
treatment; though, endogenous retroviruses (ERVs) remain a concern.11   
Endogenous retroviruses are gene sequences embedded in the genetic materials that are 
passed on to progeny via germ cells. There are tens of thousands of ERVs entrenched in 
mammalian DNA with estimates that human ERVs (HERVs) comprised between 5-8% of the 
total human genome.12 These are mostly traces of ancient viruses that do not function because 
they are missing large section of their own gene sequences; however, these traces have been 
found in connection with schizophrenia,13 multiple sclerosis, and a number of cancers.14 The 
leading candidate for xenografts, pigs, will also likely contain thousands of ERVs buried in 
their DNA, effectively making porcine endogenous retroviruses (PERVs) invisible until they 
activate and express symptoms. In addition, the ways in which ERVs are activated are not fully 
understood and may not activate for years or decades. 
This provides another set of issues in regards to the novelty of the infection and its 
symptoms. The worst case scenario is similar to the HIV/AIDS pandemic. Retroviruses are 
persistent infections which remain clinically quiescent for long periods before showing the 
symptoms of disease.15 A lack of information and understanding about the virus could allow it 
                                                             
11 Bernhard J. Hering, David K. C. Cooper, Emanuele Cozzi, Henk-Jan Schuurman, Gregory S. Korbutt, Joachim 
Denner, Philip J. O'Connell, Harold Y. Vanderpool and Richard N. Pierson III, The International Xenotransplantation 
Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 
diabetes – Executive summary, Xenotransplantation, 2009: 16 196-202 
12 Ryan F.P., Human endogenous retroviruses in health and disease: a symbiotic perspective, Journal of the Royal 
Society of Medicine 2004;97(12), URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079666/ 
 13 Yolken, Robert, Viruses and Schizophrenia; a focus on herpes simplex virus, Herpes 11:2(Suppl):83A-88A, 2004, 
Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins School of Medicine, 
Baltimore, Maryland, URL: http://www.ncbi.nlm.nih.gov/pubmed/15319094 
14 Ryan F.P., Human endogenous retroviruses in health and disease: a symbiotic perspective, Journal of the Royal 
Society of Medicine 2004;97(12), https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1079666/ 
15 Bernhard J. Hering, David K. C. Cooper, Emmanuelle Cozzi, Henk-Jan Schuurman, Gregory S. Korbutt, Joachim 
Denner, Philip J. O'Connell, Harold Y. Vanderpool and Richard N. Pierson III, The International Xenotransplantation 
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to spread and infect large portions of the general population. In addition to this, there are no 
clues to how an intact or partial PERV would interact with the human body outside a direct 
expression; as noted above, the associations between HERVs and illnesses such as 
schizophrenia, MS and cancer have only recently been observed.16   
Within the last two decades there have been a small, though significant number of 
xenotransplant patients of various types. Studies of these patients have found no evidence of 
ERV infection. Some however, did demonstrate evidence of micro-chimerism showing that 
they continued to have a number of replicating porcine cells in their bodies that would 
provide ongoing exposure to gene sequences that would include PERVs.1718   
In August 1998, The Lancet published three research articles on the subject of PERVs and 
the susceptibility of humans to infection. Two of the articles showed no indication of infection 
to people who had received living pig tissue. The third showed that invitro, PERV shed by pig 
kidney cells could infect human cells.19 As mentioned previously, subsequent testing has failed 
to find or produce PERV infection; yet biomedical science has shown issues in replicating 
published medical studies. Pharmaceutical companies Amgen and industry rival Bayer both 
revealed that they were unable to reproduce findings to replicate more the two-thirds of 
published studies identifying possible drug targets.20 Bayer HealthCare in Berlin in particular, 
                                                                                                                                                                                                    
Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 
diabetes – Executive summary, Xenotransplantation, 2009: 16 196-202 
16 Jern, Patric, and Coffin, John M., Effects of Retroviruses on Host Genome Function Annual Review of Genetics 
Vol. 42: 709-732 (Volume publication date December 2008) DOI: 10.1146/annurev.genet.42.110807.091501 
17 Ibid. 
18 Microchimerism is the presence of genetically different cells in the subject as a result of exposure to another 
subject. The most common form in humans is feto-maternal micro-chimerism, where foetal cells pass through the 
placenta and have cell lineages within the mother decades after exposure.     
19 Grierson, Simpson, FindLaw.com – For Legal Professionals, The Low Down on Xenotransplantation, URL: 
http://www.findlaw.com/12international/countries/nz/articles/1526.html  
20 Prinz, Forian, Schlange, Thomas and Asadallah, Khusru, Believe it or not: how much can we rely on published data 
on potential drug targets?, Nature reviews, Drug discovery, 10; 712, September 2011, DOI: 10.1038/nrd3439-c1 
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published that they were unable to in 47 of 53 or 89% of apparently ‘landmark’ studies; in a call 
to raise standards of preclinical cancer research.21 
According to Prinz et al., this indicates the limitations of the predictivity of disease models and also 
that the validity of the targets being investigated is frequently questionable.22 Meaning, that while the 
study was focused on repeating drug trials, this has consequences for all biomedical science 
and in particular relevance to this study, the predictive credibility of disease models and risk 
assessments based on those models that were used to inform public concerns regarding 
xenosis. So while there is no recent evidence to suggest a likely risk of infection through 
xenotransplantation, the ability of researchers to replicate the original Lancet studies appears 
to be substantially less than the expectations many might assume or claim, and as such, might 
not be considered to be evidence of low risk in of itself being that in the absence of hard data, 
attempts to assess risks and develop a rational policy are excises in reasoned speculation.23 
Indeed, recent data suggests PERV expression and interaction with human cells i.e. xenosis 
infection, while unlikely, is possible. Proponents of XTP have cited the use of breeding 
pathogen free pigs that in reality contain PERV variants. PERV-C while unable to infect human 
cells, PERV-A/C recombinant viruses are able to infect human cells and exhibit high viral 
loads, precluding assertions for PERV-C pig populations being free of infectious competence.24 
However, rather than risk a more virulent PERV-A/C recombinant the International 
Xenotransplantation Association recommends using pig populations with low viral loads of 
                                                             
21 Begley, C., Glenn and Ellis, Lee M., Drug Development: Raise standards for preclinical cancer research, Nature 
483, 531–533, 29 March 2012, DOI:10.1038/483531a 
22 Prinz, Forian, Schlange, Thomas and Asadallah, Khusru, Believe it or not: how much can we rely on published data 
on potential drug targets?, Nature reviews, Drug discovery, 10; 712, September 2011, DOI: 10.1038/nrd3439-c1 
23 Chapman, L., Speculation, Stringent Reasoning and Science, 1999, 77, 68-69,Bulletin of the World Health 
Organisation, URL: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2557575/ 
24Fei Guo, Xiaowei Xing, Wayne J Hawthorne, Qiong Dong, Bin Ye, Juan Zhang, Qi Liang, Wei Nie1 and Wei Wang, 
Characterization of PERV in a new conserved pig herd as potential donor animals for xenotransplantation in China, 
Virology Journal 2014, 11:212, DOI:10.1186/s12985-014-0212-1, URL:http://www.virologyj.com/content/11/1/212 
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PERV-A and PERV-B with lower probabilities of xenosis transmission. So while transmission of 
PERV variants is generally accepted to be low, it remains a permanent risk of XTP research.252627 
 
XTP and Ethics in New Zealand – Governmental Response 
 
The concern about xenosis as a consequence of xenotransplantation peaked in August 1998 
when The Lancet published three research articles on the subject of PERVs and the 
susceptibility of humans to infection. Two of the articles showed no indication of infection to 
people who had received living pig tissue. The third showed that in a lab, PERV shed from a pig 
kidney could infect human cells.28 
At the time these papers were published there was no distinction between 
xenotransplantation and any other type of clinical trials in New Zealand.  XTP was therefore 
subject to the requirements of safety under the Medicines Act 1981.29 The Ministry of Health’s 
concern about ERV xenosis meant that the Minister declined all applications for clinical trials – 
amounting to a de facto moratorium.30 
                                                             
25 Burlak C, Wilhelm JJ. Xenotransplantation literature update, September—October 2014. Xenotransplantation 
2014; 21: 584–587, 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. 
26 Fei Guo, Xiaowei Xing, Wayne J Hawthorne, Qiong Dong, Bin Ye, Juan Zhang, Qi Liang, Wei Nie1 and Wei Wang, 
Characterization of PERV in a new conserved pig herd as potential donor animals for xenotransplantation in China 
Virology Journal 2014, 11:212DOI:10.1186/s12985-014-0212-1, URL:http://www.virologyj.com/content/11/1/212 
27 Hering, Bernhard J., Cooper, David K. C., Cozzi, Emmanuelle, Schuurman, Henk-Jan, Korbutt, Joachim, Gregory 
S., Philip J., Denner, O'Connell, Vanderpool, Harold Y., and Pierson III, Richard N., The International 
Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet 
products in type 1 diabetes – Executive summary, Xenotransplantation, 2009: 16 196-202 
28 Kiessig, Martin U, V, Blusch JH, Haverich A, von der Helm K, Herden T, Steinhoff G., Expression of pig 
endogenous retrovirus by primary porcine endothelial cells and infection of human cells, Lancet, 1998, Aug 
29;352(9129):692-4. 
29 Grierson, Simpson, The Low Down on Xenotransplantation,  FindLaw.com – For Legal Professionals, April, 2002,  
http://www.findlaw.com/12international/countries/nz/articles/1526.html 
30 The Evening Post, 17 NOV 2001, Edition 3, Page 10. Diabetes treatment ban angers patients, NAPP 
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In 2001 the Royal Commission on Genetic Modification recommended a moratorium on 
trials and deferred the issue to the Bioethics Council; a governmental advisory group run 
under the Ministry for the Environment. In December 2001, Under Urgency, the 
Supplementary Order Paper (SOP) 231 was attached to the Hazardous Substances and New 
Organisms (Genetically Modified Organisms) Amendment Bill. The intention of the Bill was to 
amend the Hazardous Substances and New Organisms Act 1996; to allow time to establish a 
Bioethics Council, conduct research on environmental and socio-economic impacts.31 
SOP 231 amended the Medicine Act 1981, imposing restrictions on XTP because the 
procedure may pose threats to individuals and to the public, and may raise ethical, cultural, and 
spiritual concerns.32 In May 2005 The Medicines (Specified Biotechnical Procedures) Amendment 
Bill extended the moratorium controls on xenotransplantation to 31 December 2006, with the 
ability for this to be extended by Order in Council if considered necessary. 
After this time, the restrictions on XTP meant that that an application to MedSafe for an 
exemption under Section 30 of the Medicines Act (1981) could be requested. As the legislation 
currently stands, xenotransplantation is listed as a restricted procedure in Part 7A of the 
Medicines Act, and can only be authorised by the Minister of Health.33 For any application 
looking to be approved, clinical trials of xenotransplantation must be deemed to not pose an 
unacceptable risk to the health and safety of the public, and any ethical, cultural, and spiritual issues 
associated with the procedure must have been adequately addressed.34 
                                                             
31 Peterson, Dana Rachelle, Background Paper No 26, Genetic modification: A resource document for New Zealand 
MPs, February 2002, Parliamentary Library, http://www.parliament.nz/NR/rdonlyres/4CA0C507-3047-486B-8E6C-
DFEBE9AB761E/416/BP26_GeneticModification3.pdf p. 21 
32 Ibid. 
33 Gene Technology Advisory Committee, GTAC Guidelines for Preparation of Applications Involving Clinical Trials 
of Xenotransplantation in New Zealand, September 2007, Ministry of Health, New Zealand, p 1 
34 Ibid. 
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International Response to XTP risk 
 
Concerns regarding xenosis were not isolated to New Zealand. The Governments of Canada, 
Spain, The United Kingdom and The United States were also quick to put measures in place to 
not only help define the associated  issues but also regulate, and in many cases, impose a 
moratorium-type hold on clinical trials.35 
The World Health Organization (WHO) also expressed concern about the risk of xenosis and 
in 2004 the member states of the WHO adopted a resolution addressing the risks associated 
with xenotransplantation; urging member States to allow xenotransplantation only when effective 
national regulatory control and surveillance mechanisms overseen by National Health Authorities are in 
place.36 Additionally, the WHO advisory group and other experts concluded that more effective 
measures needed to be put in place to stop the illegal performance of xenotransplantation; 
and, that greater effort was needed to address the needs of harmonised quality of xenograft 
sources and safety controls.3738 
Governments throughout Europe, North America and Oceania have had public dialogue 
regarding xenotransplantation. This has helped to produce significant literature on the public 
engagement of science (PES) and public understanding of science (PUS) which seeks to 
understand the methods, goals and intentions of the scientific community and their 
                                                             
35 Biologics and Genetic Therapies Directorate Health Canada, Revised Fact Sheet on Xenotransplantation, URL: 
http://www.hc-sc.gc.ca/dhp-mps/brgtherap/activit/fs-fi/xeno_fact-fait-eng.php 
36 Bagozzi, Daniela, Animal to human transplantation — future potential, present risk, World Health Organization, 
Media Centre, 2 May 2005, URL: http://www.who.int/mediacentre/news/notes/2005/np08/en/index.html 
37 Ibid. 
38 WHO Global Consultation on Regulatory Requirements for Xenotransplantation Clinical Trials The Changsha 
Communiqué, Changsha, China, 19-21 November 2008, URL: 
www.who.int/transplantation/xeno/ChangshaCommunique.pdf  
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relationship with the public. This will be explored further in Chapter 2, but together, these 
efforts, alongside the IXA position regarding communal consent, express a rationale that 
because the public will be directly affected by developments in biomedical science and 
technology, some measure of public sanction is needed. 
The measure of this admission appears to be in the form of governmental advisory bodies. 
In the cases of the New Zealand, the United Kingdom and Canada, advisory bodies set up 
extensive networks of workshops, published discussion documents and provided publically 
accessible conclusions and recommendations to their governments. This was communicated 
through the media and interacted with reactions within the public arena to form public debate 
and opinion. How this interaction shaped what was being discussed and how this influenced 
public policy is the topic of this thesis. 
 
Research Aims and Methodological Approach: Frame Theory 
 
Frame theory is the central lens this study views its primary data. This paper utilises the 
definition of framing put forward by Entman: Framing is an omnipresent process in politics […] It 
involves selecting a few aspects of a perceived reality and connecting them together in a narrative that 
promotes a particular interpretation.39 This is done as to shape audiences’ perceptions by 
introducing or promoting the significance of ideas when evaluating a political object.40 
To achieve success, frames are generally required to resonate with the audience by melding 
congruent ideas that may include cultural knowledge, fairy tale references or character 
                                                             
39 Entman Robert M., Media framing biases and political power: Explaining slant in news of Campaign 2008, 
Journalism, 2010, 11: 389, p. 391, DOI: 10.1177/1464884910367587, URL: http://jou.sagepub.com/content/11/4/389  
40 Ibid. 
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archetypes. Doing so enables the frame sponsor to convey information by providing a concise 
emotive direction and narrative. This is done by using conceptual hooks such as public safety 
or child welfare, in an attempt to galvanise support that crosses community schisms such as 
socio-economic status, cultural identity or religious conviction. 
Since the 1998 halt on xenotransplantation in New Zealand and its subsequent resumption 
at the end of 2006, it is relevant to investigate how the debate changed and shifted over time 
and if this change could be seen as contributing to its current legality. Seeing what frames 
were used to discuss XTP over time, this thesis will analyse events and investigate frame 
sponsors to see how they sought to shape frame usage to mould public opinion. 
The aim of this thesis is to determine how controversial policy is debated in the public 
arena, and how public discussion is influenced. Xenotransplantation provides an interesting 
case study, not only because of the potential risks, but also how these risks were received by 
broadcasting and print media and then related to the public. One reason for this is how XTP 
easily lends itself to creative interpretation. The idea of melding human and animal has 
provided countless folk tales and myths - all of which feed a collective mental association with 
modern XTP. 
Framing XTP a certain way brings with it preconceived ideas, emotions and narratives that 
draw on these associations and can influence how an audience will respond. How the 
argument is framed, might provide answers to why certain sectors of the population respond 
in the manner they do, not only to the issue, but to other community groups. Framing enables 
stakeholders such as scientists to not only explain the technical aspects but direct what 
material brought to public attention, predicting public response. This research is designed to 
identify the frames used, what was being conveyed through the available material and what 
19 
narratives were being presented to the New Zealand public. In doing so, this thesis will identify 
how the discussion took shape, what frames - if any - achieved dominance, and if so, which 
issues were addressed by dominate frames and which were overlooked. 
It is important to note at this point that identified frames in this paper are not assumed to 
dictate moral judgement. Identified frames, do not neatly fall into positive or negative 
categories. One example of this is how perceptions of medical risk came to be used over the 
course of the analysed time period; medical risk, whether high or low, was all tabled as a Risk-
Medical frame because the connection of risk to XTP shaped how XTP was to be perceived and 
discussed. 
Because of this, analysis of the particular frames in context is essential to providing insight 
to stakeholder framing; deploying frames in ways such as public health, risk, economic 
investment, potentially lifesaving technology or sensationalist, articulates clues as to what the 
stakeholder wants, and the ways in which they want the public to see the issue, and in some 
cases, the debate itself. Through analysing the debate using frame analysis, conclusions are 
able to be drawn on who is being addressed and what sectors of the population stakeholders 
are trying to mobilise. 
How the different parties used competing language, allows for greater transparency of the 
process of political and financial mobilisation. The research is designed to illustrate how 
stakeholders attempt to do this through the use of key words, arguments and metaphors over 
the specified time period. In doing this, it is intended to provoke a greater understanding of 
public debate in media and its influence on policy, while contributing to the literature on 
frame analysis and public policy. 
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The findings in this thesis will reveal that public policy debate was effectively managed by 
frame sponsors; the relative obscurity and complexity of the xenotransplantation debate 
facilitated the mobilisation of varied interests and the acquiescence of the population in the 
deployment of public resources.41 The findings should be of interest to those in the areas of 
public policy, public engagement of science and frame analysis. 
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Chapter Two – Literature Review 
 
This chapter covers the relevant literature for the public engagement of science, the concept 
of brand states and the public experience and attitude towards xenotransplantation. The 
potential medical and economic gains biotechnology presents has provoked many nations into 
funding various biotechnologies. Especially in smaller countries such as New Zealand, 
Singapore and Iceland with limited resources there have been efforts to brand countries with 
the ‘Biotechnology’ label in order to entice both domestic and international investment.  4243 
As part of this effort, there has been an increase in the public engagement with science 
(PES) in many countries. The literature regarding this development has been observed to be 
hopeful yet critical of methods and claims of success. It is these case studies of PES and their 
literature, which inform the theoretical framework of this research project. 
 
Brand States / Public Engagement / Scientific Citizenship 
 
The growth of biotechnology in smaller countries can be seen as an effort to deal with 
competitive advantage of nations in a global economy. Porter has argued that in contrast to 
traditional knowledge about national economies, industry-specific circumstances, choices and 
outcomes can overshadow national factors when influencing winners and losers in the global 
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economy. 44 This can be seen in how resource-poor nations become successful despite deficits, 
inflation and high interest rates.45 
 For Porter, national competitiveness arises from how a nation’s resources are deployed 
in order to export highly productive items. 46 Biotechnology is one such area and state 
branding is one way of bolstering small economies in the global context. This is an important 
tool for driving foreign investment as Van Ham argues that a state brandings comprises the 
international audience’s perception of that nation and that having a poor brand, or a lack of 
brand affects their international competitiveness.47A notable example of the biotechnology 
brand is that of Singapore’s Biopolis, where key biomedical research institutes were brought 
together with local and international biotechnology and pharmaceutical companies. This was 
an effort designed to create and develop a regenerative bio-economy for the Singaporean 
state, which included the [recalibration of] the relationships between the biological and political life of 
the Singaporean population.4849 
This interaction of biological and political life in small nations is in many ways dependent 
on cultural factors and histories. This can be seen in the experiences of Iceland, Estonia and 
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Tonga, and their relationship with biotechnology and the issues that arose.50 Informed consent 
became an issue for Iceland as outcry grew in response to an imposed standard of presumed 
consent to acquire their health records and sample data.51 
The Estonian public, despite a history of living under state oppression during their time in 
the Soviet Union, and an apparent general disregard for the notion of public trust, it was felt 
that legislative promises of legal protection regarding employment or insurance 
discrimination addressed their main concerns regarding growth in their biotechnology 
sector.52   
And in Tonga, the lack of public consultation, and that the extended family as the 
cornerstone of identity and daily life in the Pacific Islands, shifted focus from personal 
informed consent, to notions of collective consent.53 This position in particular has significant 
implications for the New Zealand context where both Maori and Pacific identities view 
extended family and community as integral to an individual's daily experience; this is 
compared to a more individualistic approach typical of Western notions regarding informed 
consent. Later in this thesis, this disparity is shown to be a significant factor of New Zealand's 
XTP debate by how such concerns were received and reframed by stakeholders. 
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These cultural factors play heavily into what Tupasela refers to as an economy of hope.54 This 
economy of hope is the drive for personal or financial investment, not for a particular drug or 
medical apparatus, but a prospect of hope - where the production and consumption of such a 
product is set in the near future when supporters, especially actual or potential investors, can 
take advantage of these promised technological advances.55 In light of this Tupasela points out 
that money, political will or taxpayer support is being exchanged for promises; so much so, 
that the economy is virtual and, in fact imaginative, based essentially on expectations.56 
In relation to xenotransplantation and this research, an economy of hope has been 
deployed by referencing issues such as organ waiting lists or type 1 diabetes, suggesting XTP 
might be an effective treatment or cure in the near future. What tempers this economy of 
hope is the reputation of science and scientists in the country the economy of hope is being 
deployed.57 So that if particular scientists or scientific communities too often deploy the 
economy of hope without results, or if the authority of the scientific community is 
undermined by perceived failures or scandals, deployment of an economy of hope narrative is 
unlikely to resonant with an audience and fail to generate the manner of support the narrative 
is designed for. 
What has spurred the development of economy of hope narratives is the speed at which 
technological progress is progressing. Due in part to the lack of connectivity pre 20th Century 
technological advancement was significantly slower than the present. By the early 20th Century 
change in the public's daily lives by way of technological progress was occurring regularly and 
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within living memory. Due to shift, Tupasela argues that expert framing shapes the context of 
biotechnology to that of commercial and medical promise, making policy formation easier to 
negotiate. More specifically, that medical modernisation and expert framing has formed an 
economy of hope essential to medical modernisation industry wide.58 
This enables the enlistment of public resources and vision regarding development in 
biotechnology where the construction of dual roles for citizens are deployed; they are to both 
accept the discourse applied by experts and then support these research agendas receiving 
public resources - a process Tupasela describes as the construction of passive/active citizens 
and considers necessary to the medical modernisation of developed economies.59 
The concept of passive/active citizens is of direct relevance to this research as it is 
suspected that a similar process occurred in New Zealand for issue of xenotransplantation. 
What follows is how this might have also occurred for the issue of genetic modification in New 
Zealand, another significant biomedical issue for the New Zealand Public. 
The creation of passive/active citizens can be seen in the deproblematisation of consensus 
politics. Goven describes how concerns brought forward by public consultation were 
rationalised into dominant scientific and economic narratives designed to produce 
‘resignation to the inevitable’60 Due to the concerns and resistance new biological technologies 
tend to invoke, there has been an increase of the use of consensus conferences based on the 
model developed by the Danish Board of Technology.61 
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Goven evaluates the Danish model’s potential in managing the known and continuing issues 
of competency and legitimacy in policy making, by utilising the participatory approach to 
remedy the shortcomings of expert discourse; primarily by providing a counterweight to the 
previously ignored or undervalued impact biotechnology may have on individuals and 
communities. Goven outlines the Danish method of consensus models and gives an account of 
its usage in New Zealand in 1996 and 1999, the manner in which it differed in practice, how it 
came to be framed by organisers and panellists, and the implications of this for future 
attempts.62 
The origins of the consensus conferences are a notable point of difference. In Denmark the 
program was part of a wider assessment program, while in New Zealand it spawned from 
public sector scientists focused on public understanding and support of science.63 Because of 
this, New Zealand’s initial 1996 and 1999 conferences can be considered to have suffered from 
a lack of perspective and support.64 
Primary factors were twofold: firstly, organisers centred on a deficit model, seeking to 
change debate by rationalising and educating - assuming that tensions regarding genetic 
modification came from a lack of understanding or rational thought.65 Secondly, that the 
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nature of these conferences, its origin and well based concerns about bias prevented the 
recruitment of non-governmental scientists, experts and organisations. It followed then, that 
in practice these conferences were criticised for having more time allowed for expert panels 
than citizen deliberation, for lack of independent oversight and investigation, and for 
producing reports focused on technical or regulatory critiques over providing a voice for the 
public.66 
This is not to say however that the organisers of the 1996 and 1999 conferences were 
unaware or not cautious of source bias. In both examples there were dissenting voices, in order 
to give the panel, balance, even handedness or two sides.67 This does however, presents its own 
issues as there are naturally more than ‘two sides’ to complex biotechnology issues and such a 
position can be a frame in itself, undermining more nuanced positions. 
Such balance characterised by for-or-against mentalities often ignores personal, cultural or 
spiritual concerns which don’t necessarily fit into such binary issue framing. Such problem 
framing, for the most part, fails to address these concerns or attempts to place them within an 
oppositional or advocacy role in contrast to science, further reinforcing a deficit model 
mentality. Further, this duality in ideas regarding public opinion is an interesting feature of 
the XTP debate in New Zealand, especially as it is often drawn down racial/ cultural lines. A 
more in-depth analysis of this aspect of the XTP debate will take place in the Discussion 
Chapter alongside other facets of the XTP debate. 
Goven’s argument regarding the deficit model and its role in the construction of the 
scientific citizen is also seen in Irwin’s analysis of British reaction in the wake of the Foot and 
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Mouth (BSE) Crisis, as well as looking at how this crisis affected policy and consultation 
processes for the introduction of genetically modified foods.68 
After the BSE crisis, British public confidence in the effectiveness of government regulation 
and response to biological crises were visibly shaken.69 Therefore reaction to the development 
of such technologies was tempered but not wholly negative; genetically modified organisms 
(GMOs) were meet with apathy - provoked by general moods of inevitability and fatalism about 
biotechnology development with reports noting, mixed feelings about the integrity and adequacy of 
government regulation, and in particular about the scientific assurances of safety.70 Numerous public 
consultations about GMOs in food took place in an effort to explore public hopes and concerns and 
feed these in the policy process71 
Irwin asks how this factors into the construction of the scientific citizen as part of such 
processes. Noting in addition, this question’s importance now that the literature and much 
public policy among developed nations has moved on from questions of if such public 
involvement is valid, to what forms public involvement will take. While public consultations 
were focused on the increase of knowledge and transparency, it is seen as done primarily to 
increase public confidence in the government and their ability to manage and utilise scientific 
knowledge.72 
Irwin shows that despite the calls for citizen-led public consultation in Britain: it is through 
the agenda of Minister for Science, Lord Sainsbury, that by setting questions from the outset undoubtedly 
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limited discussion by determining the legitimate areas of discussion.73 Irwin describes this as pre-
framing.74 So despite the opportunities for impromptu discussion, the public consultations were 
clearly shaped and guided by format, government, researchers from market research group 
Ipsos-MORI and the advisory group experts.75 
Public discussion was so prescribed that the House of Lords Select Committee, despite 
acknowledging it developed a rich understanding within the participants, noted that the 
exercise [was] closer to market research than to public consultation.76 Because of this, the claims of 
that series of consultations and others which draw from a deficit model of public engagement 
as being citizen-led are undermined and undeserving of the legitimisation citizen participation 
offers. 
While being aware of the deficit model, government organisers repeated its assumptions by 
imagining that science and fact could be detached from opinion and judgement, and that being 
able to do so would enhance public debate. This has implications for the value of the Bioethics 
Council-led consultations for XTP as its mandate was also based on the idea that scientific fact 
could be separated from opinion by focusing on the ethical, cultural and spiritual concerns of 
the public. It is reasonable to argue that the discussion document presented by the Bioethics 
Council - which outlined the issues of spirituality, nature, identity, animal rights and Maori 
views, were similar in effect as Lord Sainsbury’s agenda-setting questions, limiting a 
potentially more diverse, representative ground-up approach to discussion in these areas. 
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These case studies have shown that the assumptions associated with the deficit model fails 
to account for the real abilities of the public to understand and react to complex scientific 
issues. Presumptions on how the public should respond to information ignore the knowledge 
and valid judgment public engagement can bring. Disregarding this input weakens the policies 
the public engagement of science is designed to inform. The changing role of the public 
understanding of science from lecturing from a position of authority to assisting in building 
informed opinions and critiques of new technology, reinforce this position.77 
How the production of ‘better informed’ citizens and debate will progress is as yet, unclear. 
While further education may indeed be the foundation of effective deliberative democracy, it 
also runs the risk of the deficit model assumptions regarding what is, and is not, legitimate 
debate on these issues and the correction of opinions not directly related to factual 
inaccuracies. 
Ultimately, the literature reviewed suggest that public engagement with biotechnology is a 
process characterized by: cultural difference informing public concerns, interaction of 
biological and political life is observed most acutely in consensus politics, the ‘economy of 
hope’, and passive/active citizens. The next section illustrates how the presentation of 
scientific information is affected by the human element in these processes, by looking at 
factors such as source and audience bias. 
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The Human Element in Engagement Politics 
 
Science, much like other specialised subjects, is prone to expert framing because much of the 
public lacks the prior knowledge or existing frames that can mitigate frame resonance in 
individuals. In light of this, science traditionally enjoyed a reputation of being factually 
unbiased by the reputation of relying on empirical evidence and the general inability of the 
public to refute or critique scientific claims. Together these factors cemented the place of the 
scientific community as position of authority on many diverse topics. In recent decades 
however controversies such as the Foot and Mouth (BSE) crisis in the United Kingdom, Bio 
Banking protests in Iceland and the meltdown at the Fukushima Daiichi nuclear reactor in 
Japan have shown the realities and fallibilities of scientific evaluations, crisis response, and 
risk assessment. 
While initially the public understanding of science field (PUS)  highlighted the disconnect 
between public ignorance of rudimentary science in developed societies, the more recent field 
of public engagement of science (PES) is dedicated to bringing scientific and public 
communities together after recognizing a lack of public confidence in science as the overriding 
concern.78 
As will be shown later in this section, the efforts in PES have generally received a positive 
reception from the public, yet those in industry and academia have more cautious in their 
response. While being mostly supportive of the idea of PES, the literature debates the 
methodology and legitimacy of the majority of large scale PES cases. Despite this, there has 
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been substantial progress showing that uncertainty is more widely accepted than previously 
thought, and that the uninitiated public is capable of engaging and providing justifiable 
positions on a wide range of scientific issues -including bio-banks, nanotechnology and 
xenotransplantation. 
Public distrust in science may well be appropriate as while the scientific method for 
observation and analysis has been generally held in high esteem, its weakness, the human 
element, can cause biased hypotheses, source material or interpretation of data. All of which 
can skew research and findings. 
Murphy looks at this human element by exploring the personal bias of expert testimonies in 
regards to nicotine addictiveness, by three different types of organisation.79  Pro-tobacco, anti-
tobacco, and independent experts would consistently favour their own institutions through 
framing evidence to support the strategy of their sponsors.80 Such obvious biases undermine 
the objectivity statistical extrapolation assumes and corrupts the foundation of how the public 
traditionally sees and understands science. 
The growing realisation that numbers are not inert, can, and have, been manipulated in 
their presentation to the public, may ultimately lead to a hostile environment for science. As 
much of science community’s interaction with the public are the statistical or lab-based 
approaches to risk management. The scientific community runs the risk of losing their 
credibility and weaken the efforts of those in PES. In addition to this, the culture of peer 
review and publically-feuding experts may well be normal within academia and industry, but 
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the public reaction is often of disillusionment and anxiety of presented risks due to lack of 
consensus.81 
Further obstacles to effective science communication are how scientists and experts react 
during engagements between the public and the scientific community. Cuppen et al. found 
that attitude correspondence, phrasing and source bias were primary factors in how scientists 
responded to material, arguments and frames, and analysed how this corresponded to initial 
expectations of both expert and lay opinions. 82 
It was found there was indeed a correspondence between negative initial expectations and 
credit given to presented opinions and materials - confirming one of their hypotheses about 
attitude correspondence and phrasing. The hypothesis failed though to predict the positive 
bias related to source and stereotypes. 83 For scientists, the lower the expectation of the public, 
the more negatively scientists viewed ‘effective negative claims’ i.e. scientists who already had 
low opinions of the public had a greater negative response to arguments centred on personal 
experience or stories. 84 
Cuppen et al. proposes that this could be the response to effective-negative claims 
activating a stereotype of an emotional irrational public. 85 Despite this, those who held the 
most negative opinions about the public evaluated public claims in a more positive light than 
negative, and perhaps surprisingly and humorously, Cuppen et al. showed that scientists 
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evaluated the claims from the public more favourably than those from competing experts in 
their field. 86 
It is theorised this may be the result of  the public exceeding the expectations of scientists 
while other expert claims or opinions fall short of professional standards, or alternatively this 
may be illustrating  a discord between disciplines' definitions, phrasing and argument 
formulation. 87 The implications for the concept of open discussion, particularly on how to 
overcome the limitations of bias, remain an issue with the public engagement of science.   
How sources are esteemed or ignored play heavily into public understanding of complex 
issues and also how experts and scientists relate to each other, interpret competing narratives 
and communicate with the public. These findings may undermine notions of ‘free’ speech and 
open deliberation - the cornerstones of public communication and engagement of science. 
While this might be the case, it does not negate these efforts but may offer partial explanation 
to specific successes and failures in the PES field. 
 
Placing the Public in Public Engagement 
 
Because of the efforts and desires of scientists and public officials to include the public, public 
consultation events such as town hall deliberations have become a regular feature in the 
process of scientific endeavour, and it acknowledges the place the public in research that 
directly affects them. 
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Pellizzoni used the case of genetically modified organisms (GMOs) when reviewing 
participatory policy making, and argues that the strengthening of the public sphere in virtue 
of itself was going to generate greater legitimacy, quality and public trust in the policy 
products. 88 The significance of Pellizzoni’s work was the focus placed on the relations between 
institutions, experts and the public and how the GMO debate across five European countries 
navigated the countering interest and uncertain public risk - utilising interviews with 
informants, workshops with stakeholders and public workshops.89 
It was found that the directive of the European Union and the European Council was toward 
regulatory policies, depoliticising debate and reducing transparency as a result of the experts 
and interest groups dominating policy formation.90 This is especially the case in areas of high 
uncertainty where knowledge may be scarce, costly or controversial; where relevant debate is 
entrusted to expert advisory bodies.91 
Public awareness of the issue can bring into challenge the single problem definition and the one 
best solution for the common good.92 Public legitimacy then would depend on the 
acknowledgement of other viewpoints, as Pellizzoni would go on to show a general scepticism 
and distrust of institutions, the view of policy makers as self-interested and too reliant on 
expert advice, and widespread sentiment that the regulatory process had been overtaken by 
scientific advance and economic interests.93 
                                                             
88 Pellizzoni, Luigi, Democracy and the Governance of Uncertainty: The case of agricultural gene technologies, 
Journal of Hazardous Materials, 2001 Sep 14;86(1-3):205-22. p. 205 
89 Ibid. 
90 Ibid, 206 
91 Ibid, 207 
92 Ibid, 209 
93 Ibid, 211 
36 
The public participants in Pellizzoni’s research had shown advanced analytical perspectives 
and understanding, had pragmatic and reasonable expectations of solutions and an acceptance 
of scientific uncertainty - essentially dispelling assumptions that the public require zero-risk 
assessments and that scientific authority is infallible compared to their own lay opinions.94 
This also undermines the deficit understanding of the public understanding of science i.e. 
that inadequate scientific knowledge leads to public opposition of scientific developments. 
What does seem apparent however, is that the lack of access to the relevant information 
determined the legitimacy of public deliberation and provides a more extensive understanding 
of risk, than a purely technical definition. What comprises relevant information is argued to be 
the transparency of source materials and argument formulation. 
As Pellizzoni identified, one of the key complaints about the media debates was that the 
differing positions, arguments or explanations were presented as given or as the set of 
legitimate concerns, with no indication on how they were formulated and how conclusions 
were reached.95 This critique has relevance for how this study views the Bioethics Council 
public engagement sessions considering their presentation of major points to those involved 
included pre-packaged information. 
Exercises in public deliberation can provide support conducive to a strong scientific sector 
through identifying and addressing public concerns and opinions, though as Walmsley points 
out, that public deliberation can risk becoming a ‘one size fits all’ approach to public 
participation and the legitimacy it can bring.96 In looking at PES in British Columbia, it was 
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argued that while there remain elusive measures of success for public deliberation, enabling 
facilitators with known pitfalls can produce indications of greater success; such as the use of 
small groups to encourage less confident speakers to express their opinions; avoiding the 
frustration that can appear; fostering dissenting opinions, asking for reasons behind voiced 
arguments and cultivating a more ‘deliberative’ mind-set more aligned with the goals of public 
participation.979899 
Walmsley concludes that deliberative discussion is not a monolithic process and can include 
many discursive processes, providing a context in which to judge public engagement 
programs, and an awareness that event aims, tasks and questions play heavily on how these 
processes take place and mature.100 This has the potential to shift more attention to how the 
questions are formulated and presented to the discussion attendees. Without such attention, 
accusations of manufacturing consent through illegitimate deliberative processes may well be 
valid. 
Additionally there was the realisation that the focus of public deliberation amongst 
uninformed publics - a reaction to the perceived over-involvement of interest groups, actively 
excludes those with investment in, or passion for these new developments. The prospect of 
choosing publics because of their lack of involvement or political engagement may seem a 
valid path for disinterested reasoning, but points to the failings of a system to incorporate the 
various publics. Because of this, Walmsley contends that the recorded outcomes of public 
deliberation should not just be successes or failures regarding consensus, but also the 
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controversies or frustrations.101 Identifying and recording issues of continued contention will 
undoubtedly complicate policy formation; however, such reporting would be more 
representative of the public outlook, present a greater level of transparency and would inform 
a more robust government policy. 
Public engagement in science policy formation will also invariably contend with being 
tailored to national or regional cultural norms. How the Canadian model of public deliberation 
for xenotransplantation was viewed and responded to by American researchers and regulators 
was approached by Allspaw. When asked about the Canadian public consultation process, 
members of the American xenotransplantation community agreed that gathering public 
opinion was usually desirable but held serious concerns as to methods that are or might be used 
to obtain and qualify opinion.102 Also challenged was the definition of the informed public; 
requiring a stringent adherence to representative sampling and more rigorous public education 
strategies.103 
While the American XTP community held grave concerns as to the validity of the public 
deliberation, it also allowed for some interesting and significant questions, including: Which 
publics should be recruited? Should an informed public be deferred to over the ‘masses’ 
despite being less informed? How best are democratic ideals served? Allowing the voices of the 
concerned and/or informed to rise above those of the indifferent and/or uninformed? By what measure 
do you judge a group to be an informed citizenry? Can a public be sufficiently informed to 
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make decisions on highly complicated scientific issues? What weight is public judgement given 
when compared to that of industry experts?104 
Much of the sentiment from these experts was characterised through Dr. David Cooper of 
the Transplantation Biology Centre of Massachusetts General Hospital: [He] would estimate that 
90% of people have no interest in [xenotransplantation] and, furthermore, the vast majority of the public 
is not informed enough to be capable of making a reasoned decision. Most of the public is likely to say, 
“This is beyond me; we need the experts to decide.”105 
Allspaw repeats this belief; that opening up the discussion to the public will mostly indicate 
how disinterested the public are about specialised bioethical debates, unless they have a direct 
interest. Thus leaving discussion subject to extremist polarisation e.g. animal rights verses 
victim advocates.106 Other considerations included that people elect representatives at state 
and national levels and it is these people who bear the burden of these decisions and 
responsibilities.107 
Most revealing, were the concerns researchers had about an informed public becoming 
objectionist and therefore becoming obstacles to progress, or that bad science policy came 
from ignorance. Such distain for bioethical processes may or may not be representative, but 
does provide a basis for more permanent regulatory or even legislative provisions for the 
public’s place in biotechnology research. For this reason, when writing on xenotransplantation 
Bach and Finberg insisted: 
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xenotransplantation should not be left to the traditional technical-based approaches [. . . that] 
before introducing a regulatory framework driven by technical considerations, an informed 
public debate is needed so that the public can decide whether it wishes to consent to clinical 
xenotransplantation at all, and, if so, under what conditions.108 
This sentiment runs counter to the idea of the passive/active citizen and continues to 
inform the idea that public engagement has been motivated by consensus building and 
delivering compliance from citizens.109 Yet efforts by the IXA to endorse and promote public 
engagement with XTP, and that population acceptance of XTP can reach as high as 82%, it 
would appear there is little cause or evidence for the organised manipulation of compliance, 
and instead point to efforts of genuine public debate performed in good faith if only hindered 
by a natural self-interest and inherent bias of stakeholders. 110111 
It is important to note that the idea of public acceptance of xenotransplantation has not 
limited to the populations of countries looking to employ this procedure in the near future. 
States lacking the capacity for their own biotechnology industry capable of XTP procedures 
may expect access to the technology as the ‘fair quid pro quo for their acceptance of the risk of a 
xenogeneic pandemic, their agreement to prohibit rogue xenotransplantation operations and their  
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obligation to monitor their populations for emerging [xenosis].’112 If this does become the case, it will 
be interesting to observe how these concerns of economic disparity and public health play-out 
on a global stage. 
As shown above, the process of discussion and deliberation is inherently fraught with 
complications. Not addressing these concerns would risk alienating the public and foster a 
hostile environment for scientific work, investment and eventual consumption of biomedical 
products. If public deliberation is considered appropriate for new biotechnology development 
and distribution to the public, open citizen deliberation will be the key to informing and 
achieving meaningful consent or dissension. 
This chapter focused primarily on the public engagement of science. Chapter 4 expands on 
how framing influences public discussion in this area and shapes public policy as a result. It 
also explains the Methodology for this research and provides an overview on the research 
method of frame analysis. Together, Chapter 2 and Chapter 4 inform the research and analysis 
of the dataset and place the conclusions in context while Chapter 3 will provide further 
context for xenotransplantation by looking at the history, progress and reaction to the 
procedure. 
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Chapter Three – XTP Context: History and Regulation 
 
This chapter will provide context for xenotransplantation by briefly describing a history of 
success and failure in the xenotransplantation field, presented in chronological order. This will 
bring the reader up to date with the subject of xenotransplantation (XTP) and its place in the 
modern medical and societal context. As this history moves forward, the challenges of XTP will 
be described; highlighting the difficulties faced and how these difficulties have been responded 
to by Government institutions and non-Governmental organisations. This is followed by a 
review of how publics around the world have responded to the potential risks and benefits of 
xenotransplantation. 
The history of practicing xenotransplantation starts as far back as 1501 in modern day Iran, 
when a piece of dog skull was used to stem a head wound.113 However it wasn’t until 19th 
Century that XTP was used with any sort of regularity. The majority of early cases were xeno-
transfusions that took place in Western Europe, most commonly in France.114 Because of the 
ignorance of the species barrier, these generally resulted in poor outcomes for the patients, 
notably death. Those patients that were considered a success in their time are more recently 
considered to have improved in spite of these transfusions.115116 
Progress in xenotransplantation, as in many areas of medicine, was stunted because of the 
lack of communication and the false perceptions of growing success. Early pioneers such as 
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Scottish physician John Henry Leacock failed to gain the notoriety that would’ve decreased 
patient suffering and even lives lost.  During 1812-1816, John H. Leacock showing in eight 
xeno-transfusion trials, in which the donor and recipient must be from the same species, it was 
the perceived success of other cases and the need of replacement blood and tissue drove 
further experimentation that ignored the species barrier for almost 150 years.117 
It was not until two Frenchmen, Mathieu Jaboulay and Alexis Carrel preformed what may be 
considered the first true organ xenotransplantation in 1906 that it was hypothesised of the 
difference hetero (different species) and homotransplantations (same species) could make. 
During 1909-1913 Surgeons Unger and Schonstadt used Japanese macaques as source animal 
and from 1920 Russian-born Voronoff also attempted solutions to the issue of rejection by 
using a sister species i.e. apes, as a donor source.  This research period also identified the 
difficulties of acquiring an adequate supply of source animals, in this case, apes; an issue that 
was revisited in later discussions about potential xenograft sources.118 
While there was promising results during this time, including the production of urine and 
the decline of glycosuria attributed to xenotransplantation surgeries, there was a decline in 
research for forty years until immunosuppressant techniques were considered sufficiently 
improved to continue.119  
After a partially successful attempt where the patient survived 63 days after transplant, in 
1964 a 23 year old school teacher received a chimpanzee kidney and survived nine months 
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before succumbing to an acute electrolyte imbalance coupled with infection – providing proof-
of-concept regarding the feasibility of long term xenotransplantation of an organ.120121 
Attempts to replicate the success of whole organ transplants have been met with constant 
failure, including the now infamous ‘Baby Fae’ who did not survive long after receiving a 
baboon’s heart in 1984 despite the new immunosuppressive agent FK506.122 Further attempts 
failed in 1992, 1993 and 1996.123124 In 2000 however, there was success with extracorporeal 
(outside of the body) xenogeneic liver perfusion as a bridging technique for 
allotransplantation. However, bridging procedures are inherently short term and with 
advancements of liver and kidney dialysis, using extracorporeal xenogeneic techniques is 
unlikely to be in the best interests of the patient considering the risk of rejection and 
established alternatives.125 
Finding a replacement for allotransplantation of organs and tissue has also spurred 
alternatives other than XTP. Biomedical 3D printing, where the technology is being developed 
to grow organs for patients from their own cells is a burgeoning competitor to XTP. In the 
coming years advocates may have to prove that XTP is a robust technology when presented 
with alternatives. 
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This being said, modern XTP procedures are likely to remain competitive as the source 
tissue is easily scaled up to mass production while 3D printing in medicine, as with other 
personalised approaches, is restricted by its tailored design as well as the cost and complexity 
of specialised equipment and biomaterials. Additionally progress in immunosuppression and 
cell encapsulation technology has led to numerous successful islet xenotransplantation 
procedures to date. This suggests that while xenotransplantation is currently restricted to 
cellular transplants, it appears the technology will be able to compete effectively against the 
rising alternatives as well as providing a greater range of products.126 
Xenotransfusions may provide an adequate testing ground for public perceptions of XTP as 
red blood cells do not carry DNA, xenotransfusions can offer an opportunity as a testing 
ground for the feasibility of the practical and ethical concerns of large scale 
xenotransplantation. Such efforts however, may be little more than an exercise in the 
attitudes to foreign bodies within patients, rather than a necessity; there is little need for 
xenotransfusions in many countries where allotransfusions provide sufficient sources of blood. 
Attempts to increase xenotransfusions in these areas will not benefit patients, but subject 
them to a socio-attitudinal experiment acting as harbinger for organ xenotransplantation. 
The outright rejection of xenotransfusions may be premature and hurt less developed 
countries where there is a need for safe blood substitutes. Nigeria for example, where blood 
transfusions are the second biggest cause of HIV/AIDS transmission, or South Africa where in 
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certain regions HIV/AIDS infection stands at 40%.127 Despite the urgent need for an alternative 
in said areas, the scientific community should be wary of turning the developing world into a 
proving ground for medical technologies such as xenotransplantation, something it has 
already been accused of doing in the recent past.128129 
Concerns such as these prompted a position statement from the International 
Xenotransplantation Association (IXA), originally published in 2003, which presented a 
number of recommendations in an effort to standardise clinical precautions and ethical 
considerations.130 These included recommendations related to the selection of adequately 
informed, appropriate recipients; animal welfare, safety issues and a favourable risk/ benefit 
assessment based data. 
In 2009 the IXA, feeling the recommendations had been well received, produced a consensus 
statement extolling the regulatory models in The United States of America, Europe and New 
Zealand. It was seen that these nations in particular had converged around key concepts 
outlined in the IXA’s earlier position statement: being that for any individual nation’s XTP 
policy to be successful it would require a standardised approach amongst nations. 
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This reinforced the existing 2004 World Health Assembly Resolution WHA57.18, 2, 1 which 
urges member states: 
(1) To allow xenogeneic transplantation only when effective national regulatory control 
 and surveillance mechanisms overseen by national health authorities are in place. 
(2)  To co-operate in the formulation of recommendations and guidelines to harmonize 
global practices, including protective measures in accordance with internationally 
accepted scientific standards to prevent the risk of potential secondary transmission of 
any xenogeneic infectious agent that could have infected recipients of xenogeneic 
transplants or contacts of recipients, especially across national borders. 
(3) To support international collaboration and coordination for the prevention and 
 surveillance of infections resulting from xenogeneic transplantation.131 
 This precautionary approach was seen to be required due to the nature of third-party risk 
XTP presents.132 Due to an increasingly connected world, the realities of xenotourism remain. 
National safeguards such as specific legislation or continued surveillance of patients are 
undermined by regimes that would allow XTP despite limited or non-existent regulatory 
frameworks designed to manage the risk of xenosis; analogous to an unimmunised individual 
risking the herd immunity of a community.133 
Standardised regulatory frameworks are desirable because of how it can protect consenting 
and non-consenting populations from xenotourism and its associated risks. As such, much of 
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the literature is directed in gauging attitudes towards xenotransplantation and the factors 
influencing these attitudes. While a clear acceptance of XTP is preferable for those hoping to 
further the technology, the nuances and concerns that factor into the acceptance or rejection 
of XTP, can identify conflict and inform a more robust policy internationally. 
Perhaps unsurprisingly, public concerns regarding XTP are seen to be nation specific. The 
tone in Europe, it appears, is that of unless XTP provides a cure, it is ‘better the devil you 
know’ when it comes to medical technology. Persson et al. (2003) showed that in Sweden there 
was a positive reaction to cell or tissue transplants, more so than organ transplants.134 
Deschamps et al. (2005) showed that in France attitudes to porcine islet transplants were 
favourable, but 68% would refuse if it did not exempt them from insulin injections. After 
further information was presented, 71% would rather not take the risk associated with an XTP 
procedure.135 And in the Netherlands, Kranenburg et al. (2005) showed that 67% of patients 
waiting for a kidney transplant would rather wait four years for a human transplant than 
undergo XTP.136 
How populations respond to XTP is multifaceted and can be altered in ways not 
immediately observed. Rios et al. (2007) demonstrates that British and Irish residents overseas 
conform to the attitudes of their new homes; however, this opinion was also informed by more 
obvious cultural divides. This includes correlation with previous attitudes to 
allotransplantation; gender, where males were more favourable to XTP; and religion, atheist 
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and agnostic were more positive towards XTP.137 Other factors have also included education 
and attitudes held by spouses.138139 
The choice to focus on British and Irish migrant communities in Spain is interesting as it 
observes how attitudes about XTP may conform according to new surroundings. It does 
however present a dataset of British and Irish migrants who chose to travel to Spain and as 
such, are more likely to be financially secure, meaning they could potentially afford the 
procedure. This may suggest wealth also factors into positive opinions of XTP, as it is a viable 
option for the extension of life and quality of life for those who could afford the procedure or 
adequate insurance.140 
Martinez-Alarcon et al. surveyed those on liver and kidney waiting lists and showed that  
attitudes shifted depending on a risk, compared to allotransplantation; a comparable risk to 
allotransplantation results in a strong majority finding XTP favourable, but if XTP involved 
more risks, then favourability dropped to 8%, with 21% unsure.141142 Interestingly, if XTP was 
offered as a bridge to allotransplantation while on the transplant list, 44% viewed this 
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favourably and 29% unsure. But of those that would accept XTP as a bridge, 90% would not 
have further intervention to insert a human organ if the xenotransplant functioned well - 
perhaps suggesting many of those who answered “unsure”, or were simply waiting for the 
technology to be proven, similarly to the 'better the devil you know' attitude mentioned in the 
European studies mentioned above. 
One might expect those on waiting lists hold a high percentage of favourability toward 
xenotransplantation, likely because they hope to receive the benefits of this technology. Yet as 
seen in other studies, the correlation between attitudes about allotransplantation and 
xenotransplantation appears to be the foremost factor. Additionally, there was little difference 
in attitudes between the patients on liver and kidney waiting lists, which is significant, 
because liver dialysis is a burgeoning technology whose viability is not proven, compared to 
kidney dialysis which is a routine procedure.143  
This suggests that for many, self-interest may not override other factors when considering 
XTP as a viable alternative. Perhaps for this reason, a definite but not overwhelming majority 
of healthcare workers approved of XTP, as shown by Rios et al. (2006).144 Of health workers 
surveyed, 67% were in favour of XTP, with 26% undecided, this is compared to the general 
public control group’s response of 74%. 
Hospital personnel varied in accordance to their position within the healthcare system.145 
Front line personnel such as physicians and nurses, who are exposed to third risk associated 
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with XTP, were surveyed as being the most in favour of XTP. In comparison, healthcare 
assistants and ancillary were not so much against XTP donation of organs, but categorised their 
opinion as undecided.146 
Whether being front line medical personnel or patients on waiting lists, what is striking is 
the expression of goodwill being shown in relation to this technology, from both those it might 
help or endanger. Self-interest appears to be mitigated by a vast assortment of factors - 
informed by empathy, morality, rationality and education. The majority of regulators have 
rewarded that goodwill with efforts to standardise safety and ethical concerns across nations. 
This chapter has sought to introduce the subject of xenotransplantation to the reader and 
place it in a historical and modern context. The following chapter will do the same for the 
public engagement of science - discussing how the public is introduced to and interacts with 
science and technology through issue framing; and, then how this has been applied to this 
research. 
 
 
 
 
 
 
                                                             
146 Ibid. 
52 
Chapter Four – Methodology 
 
This chapter explains frame theory and its use in this research. The first section builds upon 
the framing theory introduction in Chapter 1 by presenting how framing is used to shape 
discourse and what this means for both those taking part and those observing. 
The news media is essential in how the public interacts with local and international issues. 
The following section will show how the media was shaped by their relationship with 
government, how those in industry and advertisers became the pre-eminent framers and how 
this is being challenged by public relations experts and internet discourse. These 
developments, in particular the internet, will inevitably change the nature of public discourse 
and can serve as an effective tool in the communication of science. The final section outlines 
more of the specifics of this particular research approach used in data evaluation for this 
project - including the definitions that are being used, a template of use for the prominent 
frames and the dataset sources being employed to analyse the discussion of 
xenotransplantation in New Zealand. 
 
Frame Analysis 
 
Frame analysis is the theory that when the public is informed of an issue there is the 
opportunity to influence the audience according how an issue is framed. A common example is 
a news report about a protest; a might be used frame to emphasise free speech, thus directing 
what is said, heard and understood about the protest according to that organisation of 
thought. The same protest could also be framed in a way that provokes thought on public 
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safety, public pressure on the government or economic cost. In either case, the frame implies a 
logical format in which to organise debate and positions arguments outside the presented 
frame as awkward or illogical. 
Issue framing can exert significant influence on the uninitiated, as individuals are sensitive 
to accessible information whilst in the process of formulating arguments, decisions and 
expressing opinion. The effect of this however, can be mitigated through prior knowledge, 
even more so if the prior knowledge was recently used.147 Because framing-on-introduction can 
be so pervasive it can paradigmatically dominate news stories, which in turn can dominate the 
audience i.e. when an issue is introduced and subsequently referenced, a particular frame can 
become the dominant lens it is viewed though. 
This has significant implications for public discussions, particularly when dominant frames 
are linked to hegemonic processes such as public submissions on public policy; which, 
according to Entman, may erode the potential for a democratic public sphere by limiting the 
range of debate.148 
Frame analysis was initially tied, in large part, to framing by television media as practical 
considerations, such as relatively short broadcast times and the drive for viewership, made 
issue framing integral in the modern news scape.149 Framing enables the development of 
problem identification, problem description and structure formulation, and as such has proven 
itself in the quick, effective conveyance of knowledge.150 Due to this its usage is not restricted 
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to news media.  Education for example, provides an effective model of how the same issue can 
be framed according to its audience. Teachers are presented with scholastic concerns by 
administrators - such as low grade medians within a government funding frame, rather than 
effective teaching or student management frames. The teacher in turn frames low grades as a 
personal issue for students, perhaps selling them a potential job or future based on extra 
effort, in the hope of mobilising their support.151 
Mobilisation may be the most significant reason for problem framing through frame 
alignment; frame sponsors produce and invoke frames with the intent of matching these 
frames with the interests, values, and beliefs of the audience they are attempting to mobilise. 
In practical terms, the use of conceptual hooks such as child safety, freedom or justice hold 
broad appeal, cutting across societal cleavages by achieving frame resonance (identification) 
with a large audience.152 This is when the audience links the invoked frame to their own 
personal experiences, philosophies and faith.153 In this manner, individual motivation can be 
socially organised by accessing existing belief structures and culture. 
These structures act as categories of thought and action that are drawn upon to shape 
interpretation of the problem and the frame.154 The broadest conceptual hook is often desired, 
as specificity might alienate certain individuals or communities, generate or isolate issue 
stakeholders and imply variant solutions.155 
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Different frames can substantially transform how an issue is viewed and thus frame 
divergence is able to shift the focus of the issue, mobilising rival sectors of society over 
different interpretations over one policy issue.156 Gamson and Modigliani (1987) envision 
contesting frames in an arena: 
Every public issue is contested in a symbolic arena. Advocates of one or another persuasion 
attempt to give their own meaning to the issue and to events that may affect its outcome. Their 
weapons are metaphors, catch phrases, and other condensing symbols that frame the issue in a 
particular fashion. 157 
How this affects debate is predicated on how frame sponsors and their audiences react to 
frame divergence. Those who continue to debate under contradictory frames will toil under a 
context suited for polarisation, escalation and protracted disagreement.158 Counter to this, 
frame convergence, which is characterized by compromise, is attuned to negotiation and 
substantive agreement.159 This in part is how framing affects its audience, but also the 
discussion itself. 
Frames, it is argued, are able to provide a shift in focus which reprioritises current beliefs 
rather than the inception of new beliefs.160 I.e. framing doesn’t change beliefs, it allows for 
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prompt accessibility of existing beliefs into conscious thought.161 As frames are drawn from 
existing philosophies, the modern context, dominated by instant and diverse forms of 
information renders elite framing more fragile than previously thought. 162 Over the course of a 
conversation the original frame can be moderated, if not outright discarded, for another 
frame.163 
Framing and the Media 
 
This section presents how modern media is both a framer and yet is vulnerable to news 
framing for stake holders; and how the internet may or may not be challenging the authority 
of traditional media by enabling various forms of counter framing structure that are not 
hinged upon the consent of government or industry. 
Print, radio, and television media previously enjoyed unparalleled access and audience to 
political actors and events. More recently, anyone with access to an internet enabled computer 
or phone can view events, hear testimony, produce frames and reframe and publish for 
literally millions of people to view; possibly changing how the audience view and later frame 
the issue. How this emerges in practice however, is dependent on various factors - including 
visibility, audience bias, frame recidivism and counter framing. 
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This second section discusses how framing can be an effective mechanism to deliver 
complex scientific information in a more accessible form and how framing has been used this 
way in the past. 
The purpose of media framing is widely considered to be the protection of the various 
interests of privileged groups that dominate domestic society and the state, by placing them in 
a biased context.164 When looking at the American public’s response to tax cuts implemented 
by President Bush in 2001 and 2003, Bell and Entman (2011) contend this policy was not only 
tolerated but supported, due to the crucial role of elite influence over political 
communication.165  This was achieved, according to Herman and Chomsky, as through the 
selection of topics, distribution of concerns, framing of issues, filtering information, emphasis and tone, 
and by keeping debate within the bounds of accepted premises’166 
Kinder and Sanders reinforce this point by saying that the media frame will allow for points 
of controversy, but only what is deemed to be legitimate controversy - which is clearly defined 
as it will still utilise the frame as the central point around which the debate focus.167 
How media framing began to be seen as protecting interests is explained by the dynamics of 
survivability in the media industry that shifted influence from the audience to interests. 
Before advertising became as prominent as it is currently, newspapers had to cover the cost of 
printing and sale of the paper through its price. Advertising shifted the burden of revenue 
gathering, meaning newspapers could offer a price below production costs, making it 
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considerably more competitive. Those who did not rely on advertising went out of business or 
were marginalised.168 
In this context, Herman and Chomsky state: [With] advertising, the free market does not yield a 
neutral system […] the advertisers’ choices influence media prosperity and survival; thus leading to a 
narrowing of interests that need to be served to maintain viability.169 The media’s ability to frame so 
effectively comes from the reality that politicians, CEOs and activists no longer stand before 
the public in the manner they would have in the past, but instead through the media to get 
their messages to the public.170 
The owners, managers and staff of mass media make decisions about what to report on and 
how to present it, how significant any piece of news is and how they should feel about it. 
McCombs and Shaw illustrated what this can mean for current events and politics, by 
analysing the 1972 presidential campaign coverage. They showed that the emphasis was not on 
the political issues but on analysis of the campaign itself. To them, it suggested a shift from 
journalism of telling the news, to commentary on the issues; firmly asserting the influence of 
the agenda setting and framing effects of news agencies to this day. 
This conclusion however, rests on restricted informational diets - a reality of the 1970s 
news scape. Yet McCombs and Shaw’s study remains significant as to the extent to which 
highly specialised information is palatable to the general public; reinforcing traditional news 
sources as intermediaries - condensing and summarising the issue and associated concerns. 
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Despite the access to alternative informational sources via the internet, news corporations 
continue to hold authority for much of the public. Even with shifts towards the internet as the 
primary information medium for many individuals, traditional information sources have 
remained as the dominant authority for news and opinion in many countries. I.e. despite a 
large shift to the internet for news consumption, it has been shown that that the traditional 
networks' online presence remains the dominant choice.171 As this change is mostly taking 
place in the younger demographics (<30) this trend can be expected to continue as these 
populations age.172 
In addition to this, complex or specialised issues such as xenotransplantation or foreign 
policy will have ideas, opinions, emotions connected to them that don’t necessarily translate 
well into forty-second television news slots - which by nature, require substantial 
simplification or outright elimination of alternative angles outside of the expected binary 
(for/against) dynamic. 
So despite the substantial increase of information, alternate sources of information are not 
as readily available as could be assumed. Traditional news media maintains a distinct level of 
authority due reputation, political access, and resources both human and financial. Whereas 
non-traditional reporters of news such as blog authors or twitter users could be expected to be 
the white noise of political commentary unless validated by traditional frame sponsors. Graber 
(1996) argues, that despite the increase of access, the demand for political information has already 
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been reached for most people.173 And when there have been spikes in political interest and news 
consumption, Graber shows it’s not indicative of a permanent shift, but rather the result of 
other competing formats entering the fray e.g. talk shows, and more recently, social media.174175 
Kinder and Sanders also discussed the effect political awareness has on framing effects. 
While there are many people who enjoy politics, are aware of the issues through independent 
investigation that enables them to hold well thought-out and defendable positions on public 
policy – the majority of the public do not.176 Because of this, the former will be more likely to 
have their own frames and as a result will be less affected by imposed frames, than the latter 
more passive political audience. The implication being that those who have not encountered 
these issues before are much more likely to use and therefore think through the frames that 
introduce them to said issue. Essentially, that frames […] matter more to the less-informed - as they 
expressed their opinion[s].177 
Further restrictions to accessing alternate information sources are education, finances, time 
restraints or general apathy. This opens the door for public relations (PR) experts or public-
tuned scientists to organise their ideas and present them in a way appropriate for those not 
actively seeking out alternative information sources. 
Indeed the evolution of political journalism has become increasingly dominated by public 
relations staff that restricts access to political figures whilst bombarding journalists and news 
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staff with pre-packaged content of video, pictures and press releases designed to show the 
political figures and their messages, in positive lights.178 In some cases, these attempts to pre-
package political events by PR staff have caused conflict with those in the media. 
Canadian Prime Minister, Stephen Harper, became notorious for shunning the media 
gallery in favour of choosing the journalists who could ask questions and by only giving 
Government or military photographers permission or the opportunity to document certain 
events.179 This then became the basis for its own media frame of the bubble.180 Even editors who 
consciously refused the use of those releases and hand-outs have admitted to its effect: E.g. It’s 
always in the back of your mind. and There’s some small psychological impact.181 
As scientific issues gained greater levels of coverage in the media and became directly 
relevant to public policy in the latter half of the 20th Century, the application of frames in this 
area gained larger attention. Analysts began to focus on the communication of science, the 
public understanding of science and how this affected science policy discussion and outcomes. 
 
Framing in Science Communication 
 
Shaping issues for public consumption though, is not an inherently negative proposition and 
remains an effective tool for communication. For scientists, who now more than ever are being 
called to justify and defend their work in the public arena, framing is an effective tool for the 
reduction of complex topics for public consumption. Even for those scientists or experts 
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experienced or trained in public interaction, doing so is fraught with the dangers of 
misunderstanding, fear or impatience. 
Framing a particular issue then can enable the effective communication of science that 
guides both the scientist in the presentation of issues and the audience in understanding them. 
Despite being an effective tool, Nisbet argues that particularly when the subject of debate is 
science, the public use their social values to pick and choose ideologically-friendly 
interpretations - not necessarily those provided.182 
Making judgment and forming opinions based on ideology, in the absence of readily 
understood information, is offered as the cause for the public’s mostly modest understanding 
of science; this is propagated and reinforced by homogenous networks and selection of media 
sources that reinforce existing ideological or religious views and behaviour.183 
Because of this, framing presents to scientists an effective method in the communication of 
science to the public; by helping them to generate interest or concern, influence personal or 
political behaviour, unite the public, or rally other scientists around shared goals. Reoccurring 
frames familiar to the public have been shown to cross different scientific issues, include 
nuclear power, stem cell research, and Evolution/Creationism in schools. This attests to their 
effectiveness in reducing and presenting complex information. 
Members of different scientific communities showed they were able to provide a solution in 
light of some of the concerns raised. E.g. scientists involved in the nuclear power debate in 
America found that social progression and the middle way frames worked successfully. In this 
context, nuclear power was seen as the solution between concerns about CO2 emissions 
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balanced against the continued rise in energy needs and energy independence; both of which 
are considered an issue of national pride and security.184 
For those debating the teaching of evolution in American schools the frame use was 
identical, with social progression featuring prominently; this was on the basis that an 
understanding of evolution is essential to the way vaccines and cures are derived.  The middle 
way frame also featured predominantly - outlining that there was no reason why religious 
ideas could not exist alongside scientific ones.185 
This was followed by many religious leaders who came out in support of evolutionary 
teaching in schools, agreeing that they need not be incompatible. Though, success in framing 
does not always produce such harmonious results. As seen when Richard Dawkins published 
his book, The God Delusion, once again placing the issue of evolutionary education in conflict by 
instigating and driving Science vs. God/Religious vs. Science frames as well as sound bites for 
an enthusiastic media.186 
Similar cross-issue framing can be seen in the British media’s use of metaphor when 
discussing biotechnology. Between 1973-1996, the biotechnology debate was covered by seven 
‘super categories’: Promise (economic and progress), Scare, Other Science (analogous technology), 
Religion, Natural Order, Gene Person, and (the mad) Scientist or Designer.187 
While some of these metaphors were defined as clearly positive or negative, a third 
category of Popularisation (including examples of the Gene Person’, Engineering and Archaeology, 
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was considered to be aimed at informing the public of the issue and had the ability to be used 
by both affirmative and negative camps on the particular issue.188 
One such example of a popularisation frame was the concept of the Gay Gene. It was initially 
used by some to derogatively describe homosexuality as a genetic mistake; though using the 
same Gay Gene frame, this argument was countered by the idea that homosexual behaviour is a 
result of natural biological occurrences and not a matter of choice.189 
Metaphors used in framing vary in response to their pertinence to the current issues, yet 
some metaphors remain in use. Suggesting, such imagery will continue to be valid as they 
provide clear partition between countering sides and because archetypes such as 
Frankenstein’s monster remain in the public psyche.190 
Cultural relevance is key for this effect to work as using Frankenstein’s monster whilst 
framing will have little resonance with a community, culture or generation that is unfamiliar 
with that archetype. As such, Zemanova examines cultural relevance during framing as an 
important factor in audience resonance and subsequent mobilisation in social movements. 
Zemanova (2009) argues it is because framing taps into cultural representations - when looking 
to create a resonant frame language, images and emotions matter.191 Zemanova observes that cultural 
representations in framing are changed according to cultural schisms,  offering that as long as a 
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frame is able to communicate and provoke an emotional response, it will continue to resonate 
with its target audience.192 
This can lead to its own dilemmas, as the media’s propensity to focus disproportionately on 
the negative, produces fear-inducing news frames because of their emotional resonance.193 The 
impact of this can scare a crisis into existence, causing public servants to act on an emergency 
of hyperbole to stem public panic.194 As such, framing runs the risk of being a tool of fear-
mongering and producing poor public policy as a result. 
Reducing complex issues to the most basic emotions for the sake of resonance, takes away 
from the informative potential of issue framing and lends credibility to those who have a 
wholly-negative view on framing as merely ‘spin’. 
Framing can be a useful tool for producing effective communication with an uninitiated 
audience.  As middlemen, the media can allow scientists and experts to present their work or 
ideas in such a manner as to counter pre-existing cultural or religious ideological biases. For 
many in the media however, there is cause for concern due to the growing perception of 
conflict between news generators and reporters. 
For news generators like Government and industry officials, using the tools of PR staff, 
media packets and embedded framing enable the production of positive images. For others, 
media-experienced scientists or public relations staff and their media packages replace real 
access, and embody a denial of a free press and the check and balance it ideally provides for 
democratic systems. 
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How the media industry will react to this shift of framing power remains unclear but the 
prevalence of digital distribution as an alternate information source; from blogs to WikiLeaks, 
and the demand of digital disguises such as proxies (VPNs) and the TOR network may provide 
clues to future resistance to the framing by traditional authorities. 
In order to analyse these interactions between the public, government and the science 
industry as this research does, the latter half of this chapter will outline certain specifics of the 
research - including definitions, how the coding was performed and how the dataset was 
compiled. 
 
Definitions 
 
For much of the early history of framing theory there was an issue of how to define the 
phenomena that was being observed. Entman (1993), called for a cohesive frame analysis 
paradigm – as he lamented the inconsistency of even the most core terms, conceived a single 
location where framing concepts could be brought together, exposed and explored.195 This 
general mission statement on framing theory did not go unchallenged.196 D’Angelo (2002) 
claimed there was no need for a meta-framing paradigm, and that strength came in diversity.197 
That a diverse approach would form a comprehensive view of the framing process, far more so 
it is argued, than ‘fragmented findings in isolated research agendas.’198 D’ Angelo utilised 
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Lakatos’s (1974) disagreement with Kuhn (1962) and Popper (1963), who like Entman (1993), 
argued for standardised definitions and agreement on theoretical statements and methods. 
Lakatos asserted that researchers should study phenomena using many different theories [as] 
researchers are still ‘connected by a remarkable continuity which welds [...] into a research program. 
From this, it was expected that the gradual refutations of academic peer review would fuel 
scientific progress.199 Perhaps confirming Lakatos, academics such as Bedford, Entman, Gamson 
and Snow have, despite lacking a cohesive paradigm, made significant progress towards a 
generalised theory of frame analysis.200 
Entman’s definitions do provide concise definitions of key terms this paper chooses to 
utilise. Entman defines framing as selection and salience - the act of choosing a perspective to 
present, based on what information is made salient.201 Salience meaning, making chosen 
information noticeable and memorable to the chosen audience. By connecting to the context 
of the frame to information, they are processed and remembered together furthering the 
frame’s objective as they diagnose, evaluate and prescribe.202 
Making information more salient may include placement, repetition or association with cultural 
symbols.203 Yet the focus framing places on certain information is naturally to the detriment of 
other relevant information. Entman notes that most frames are defined by what they omit as well as 
include.204 This being the case it is important to note that while all framing might not be 
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deliberate or with defined purpose, information is rarely politically inert and nor is its 
selection and presentation. 
Coding 
 
Coding of the dataset focused on keywords, tone and intent in order to characterise a frame to 
a unit approximately one sentence long, which may include multiple sub-categorical frames. 
The xenotransplantation debate placed significant importance on the role of the public as both 
potential benefactor and potential victim of contesting XTP policy ideologies. In light of this, 
this paper uses a description of the collective action framework originally described as the 
call-to-action for social movements by Bedford and Snow et al.205 In the case of the XTP debate, 
it is both a call-to-action and to the buy-in of the economy of hope and active passivity. 
The structure for coding is Bedford and Snow’s Collective Action Framework: 
• Diagnostic Frame: Tell new recruits what is wrong and why 
• Prognostic Frame: Present a solution to the problem suggested in the diagnosis 
• Motivational Frame: Give people a reason to join collective action206 
 
                                                             
205 Sanfilippo, Antonio, Franklin, Lyndsey, Tratz, Stephen, Danielson, Gary, Mileson, Nicholas, Riensche, Roderick, 
McGrath, Liam, Automating Frame Analysis, Social Computing, Behavioral Modeling, and Prediction 2008, ISBN : 
978-0-387-77671-2,  p. 241 
206 Benford, Robert D., Snow, David A., Rochford , E. Burke, Jr., Worden, Steven K., Reviewed work(s): Frame 
Alignment Processes, Micromobilization, and Movement Participation, Source: American Sociological Review, Vol. 
51, No. 4 (Aug., 1986), American Sociological Association, URL: http://www.jstor.org/stable/2095581 p. 464 
 
69 
The following section will specify specific sub themes which outline certain frames and 
place them within Bedford and Snow’s Collective Action Framework. This is done to make the 
frame purpose clear, and was used in the analytical process. 
 
Diagnostic Frames 
 
 Conflict/Controversy: Reference to strong points of contention or countering views. 
Extremists, opposed/opposition, warning, critic/ism; all suggesting a tension of the 
issues and notes controversy. 
 Government Interference: Mention or tone of perceived governmental hindrance, 
filibustering and the expression of annoyance on the behalf of scientists, business 
leaders and potential benefactors of xenotransplantation. 
 Government Alienation: Expression of a perceived or real disconnect between the 
New Zealand Government and political process being described. E.g. ‘Rubber Stamp’. 
 Mad Science: The notion that science in New Zealand or others, is out of control. E.g. 
Runaway science, maverick science. 
 Person vs. Public: The direct comparison of personal gain against public risk. 
 Problem Frame: Outlines the problem that is being faced, with the solution - in this 
case xenotransplantation. E.g. transplants, waiting list, diabetes epidemic. 
 Risk - Medical: Mentions of risk, likelihood of possible outcomes, includes fears or 
threats about ERV's but also missing out on possible medical gains. E.g. HIV/AIDS, 
retrovirus vs. people dying on organ waiting lists or poorly controlled diabetes. 
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 Risk - Economic: Explicit notions or inference of economic risk. E.g. offshore, global 
biotech industry. 
 Scandal: Accusatory statements or inference about misdealing, not being to safety or 
ethical standards, potential or real illegality 
 
Prognostic Frames 
 
 Public Safety: Reference to measures in place or taken to ensure public safety. E.g. 
mentions of regulation, precaution, banned, guidelines, safeguard/s, independent or third 
party (in relation to oversight) and further research. 
 Public Understanding of Science (PUS): Reference to public engagement of science, 
possible understanding, debates with or about science, misconceptions, surveys, 
awareness, consultation, wider views, informed, public meeting. 
 Sociological Frames: Reference to ethical cultural, community, spiritual concerns or 
issues. 
 
Motivational Frames 
 
 Hope - Medical: Expectations, hope or promise regarding the medical benefits of 
xenotransplantation, including other medical gains as a result of an expansion of 
biotechnology in New Zealand. 
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 Hope - Economic: Expectations, hope or promise regarding the economic gains to be had 
of xenotransplantation, including other economic gains as a result of an expansion of the 
biotechnology industry in New Zealand. 
 Victim: Focus on individual with diabetes or those on waiting lists, the main candidates 
for xenotransplantation technology. E.g. Diabetes suffering, viewpoints and hopes. 
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Chapter Five – Data Analysis 
 
Key Features of Public Discussion 1998-2013 
 
This chapter provides an outline of the key issues and features of the xenotransplantation 
(XTP) debate, as highlighted in the research. It describes the ebb and flow of certain frames but 
also focuses on short-lived but significant frame usage. It demonstrates that frame usage was 
shaped over time by a number of factors, such as stakeholder interests, political context and 
journalistic integrity. This discussion, in turn, provides a foundation for Chapter 6, which 
explores what this case study means both for the public engagement of science and public 
policy in New Zealand. 
As expected, the data confirms that public discussion of xenotransplantation was 
dominated by those with direct interests and the ability to make those interests heard. News 
coverage was almost entirely reactive with stories often being the very press releases sent out 
from stakeholders and seldom providing considered analysis or relevant context for their 
audience. This in part contributed to frame usage being dominated by the logical reduction of 
counter framing attempts facilitated by media balance engaging with stakeholder positions. 
This in effect became a meta-framing effort which constituted an overall cost/benefit analysis. 
This is seen in the use of Hope-Medical, Hope-Economic and Risk-Benefit frames being juxtaposed 
against Risk-Medical.   
Risk-Medical framing underwent a substantive shift in usage over the time period analysed 
(see Figure 1). Initially its dominant use was to illustrate the dangers of endogenous 
retroviruses and other potential risks xenotransplantation presents. Later it was primarily 
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used to show how these risks were extremely low based on the safety of the special pigs and 
New Zealand's strict biosecurity laws, but little mention of the current risk assessment of 
porcine ERVs. Living Cell Technologies went so far as commenting on risks not associated with 
its technology; regarding the 2009 Swine Flu epidemic LCT sent press releases and commented 
on swine flu despite it being unconnected to XTP, Swine Flu being easily tested for and 
extremely unlikely in highly regulated medical grade piggery: 
LCT has special herds in Kumeu and Invercargill which have been bred from pigs isolated on the 
Auckland Islands for about 200 years, resulting in pigs which are comparatively free of viruses. 
They are also housed in bird-proof facilities. Dr Tan said regular testing of the herds showed no 
swine influenza and an outbreak of flu was more likely to occur in nature than in a regulated pig 
facility.207 
 While this could be seen as precautionary public relations, this contingency was so unlikely 
that such engagement is in effect misdirection while other stakeholders such as the 
Sustainability Council of New Zealand were still seeking public consultation on XTP, PERV and 
public risk.208 
Over time this meant there was a clear shift in frame usage - where Hope-Medical is seen to 
be growing in contrast to a consistently declining use of the Risk-Medical (see Figure 1). As the 
concerns of medical risk declined there was swift expansion in the use of the Hope-Benefit 
frame, which is characterised by the potential of economic gains. 
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Figure 1 
The 2008 and 2011 period in particular, illustrates how dramatic a shift is occurring as the 
Risk-Medical frame is all but absent and the Hope-Benefit framing exceeds an otherwise 
dominate Hope-Medical frame. Interestingly the amount of people for whom an XTP operation 
is needed was often placed in positive terms alongside how many jobs the development is 
hoped to create. 
Venture Southland strategic projects manager Steve Canny said having LCT set up a facility in 
the province was "fantastic". "This has enormous potential and could not only provide a diverse 
range of jobs in the future but also help an enormous number of people. “It is expected more than 
11,000 New Zealanders have type 1 diabetes.’209 
Framing efforts that achieved dominance by continued use during the observed time period 
were Hope-Medical and Pharma-Pig frames. The Hope-Medical frame was a constant feature of the 
public debate, by presenting that this technology had the potential to tackle the modern 
epidemics of organ shortage and Diabetes. 
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How Hope-Medical was marketed changed significantly. The Royal Commission on Genetic 
Modification’s (RCGM) report specifically mentions xenotransplantation in the context of 
organ donation – spring boarding a relatively obscure development of biotechnology into the 
public sphere, particularly in relation to the public backlash by Living Cell Technologies, then 
named Diatranz. This was due to their belief that the RCGM went outside its mandate in 
approaching the topic of xenotransplantation and that this put a hold on a promising medical 
development. 
Frame usage on the medical benefits of xenotransplantation was split between organ 
donations as a promising solution to the growing issue of organ waiting lists and type one 
diabetes. This enabled the Hope-Medical frame to be used in relation to prospective gains in 
organ replacement but was able to show promising results of islet XTP and patient 
testimonials, enabling the effective use of the Victim frame in conjunction with Hope-Medical. 
Such as the report focusing on eleven year old Sophie Foster: 
“Diabetes is quite a pain for me, because at my age a lot of people have sugary drinks and 
unhealthy food and I'm stuck with fruit and vegetables. I would like to eat other things, probably 
stuff like lollipops.'” 
She has an insulin pump, which gives regular doses of insulin through a 'port' into her
abdomen. That gives better blood- glucose control than insulin injections, but the hope is that the 
transplants will stabilise blood glucose levels even more and reduce or end the need for synthetic 
insulin. 
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This would simplify diabetics' lives and reduce the risk of complications such as blindness and 
kidney failure.210 
In the period 2003-2006, Hope-Medical became less about organ XTP prospects and more 
directly related to the issue of LCT’s Diabecell trial, and the transplantation of foreign tissue 
and cells. Once the trials were able to progress with the expiration of the moratorium, the 
Hope-Medical frame was shifted to forms of tissue other than islets that included the potential 
of transplanting brain cells in order to treat Parkinson’s disease. 
 ``We are the ultimate place in the world to build an industry out of turning pigs and other 
 animals into medical grade use,'' he said. 
``We have an opportunity to build a multibillion-dollar industry and it's sitting there, it's not like 
it's a dream, it's a real reality now.'' 
The company was also working on a treatment for Parkinson's disease and Collinson said there 
were about 2500 disorders that could be treated with animal cell therapy.211 
The Pharma-Pig frame was a consistent feature of the xenotransplantation discussion in New 
Zealand. The effect of this frame usage was two-fold; firstly it cemented pigs as being the 
dominate source for tissue, organs and cells for xenotransplantation. Secondly it was used in 
conjunction with numerous positive framing attempts including Safeguard and Hope-Medical. 
The geographical isolation of the Auckland Island pigs became of distinct importance, 
combined with acclaimed measures to ensure a standard of cleanliness of medical grade 
xenographs to serve as a viable cell and tissue source. Because of this, there was a strong 
correlation between Safeguard, Pharma-Pig and Hope-Medical (see Figure 2). 
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Figure 2 
Hope-Benefit and Southland-Hope were frames used in conjunction with the Pharma-Pig frame 
to exhibit the potential (mostly) economic benefits New Zealand and in particular Southland 
would receive, as a result of a successful xenotransplantation industry - including large scale 
piggeries and an increase in reputation in the areas of biomedical practice and investment in 
New Zealand. 
The Southland-Hope frame was an interesting feature of the xenotransplantation discussion, 
as this frame was in many ways tied to Invercargill personality and Mayor, Tim Shadbolt. The 
Southland-Hope frame emerged from the more general Hope-Economic frame which was used to 
describe the positive effects of xenotransplantation in New Zealand, not specifically medical in 
nature. 
This focused on the many economic and non-economic features that were expected to 
emerge from a successful xenotransplantation program in New Zealand. Much of this focus 
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Pharma Pig 29 57 8 15 98 0 69 63 67 25 16 5
Safe Guard 81 124 6 5 409 3 44 56 43 1 4 1
Hope Benefit 1 30 2 0 33 0 20 34 21 70 63 1
Sth Econ Hope 0 0 0 0 0 0 0 0 25 24 17 3
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looked at the New Zealand Pharma-Pig, touted as a main feature of New Zealand’s competitive 
advantage. The fact that LCT had a small piggery in Southland, and would possibly expand 
there, meant that xenotransplantation could introduce millions of dollars into the Southland 
economy. 
This became linked to Invercargill’s Mayor Tim Shadbolt, as he enthusiastically supported 
the piggery and its potential expansion. This included financial support he drew from his 
Mayoral Contingency Fund; eventually amounting to $12,000, resulting in the fund being 
revoked and renamed the Council Contingency Fund. This mirrored the financial difficulties 
LCT was reportedly undergoing due to the moratorium stalling the Diabecell trials. Therefore 
the expiration of the moratorium vindicated both LCT and Tim Shadbolt’s efforts and 
commitment. E.g.: 
The trademark smile of Invercargill Mayor Tim Shadbolt grew even wider yesterday after Health 
Minister David Cunliffe approved clinical trials of a controversial diabetic treatment involving 
pig cells. Mr Shadbolt faced derision when he insisted on rescuing pigs being culled from the sub-
Antarctic Auckland Islands, paying for the pig-feed to keep them in Southland. However, 
yesterday's announcement has given the mayor the last laugh. The genetically pure, disease-free 
pigs are to provide the cells for the treatment trials. Mr Shadbolt said the decision was great for 
the city and for diabetics. ‘‘I am hoping the story one day will be ‘Invercargill saves the world'.'"212 
 In the articles which included the Southland-Hope frame, this became an ‘underdog’ story 
which linked and benefited both parties while it was being used. This enabled LCT to be framed 
through the Grassroots framing efforts which coincided with those of Southland-Hope. 
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There were numerous short lived framing attempts. These frames generally belonged to 
two distinct groups. The first being counter-framing attempts which focused on cultural 
interpretations such as Animal Rights and the Cultural frame which focused on public 
interpretations of xenotransplantation through different lenses such as religion or cultural 
heritage. The second group of frames were attached to, or provoked by, certain events or 
context - such as those seen during a controversy or Parliamentary debate. These were frames 
tailored to specific events and generally had short term goals, never gaining salience outside 
these contexts. Details of these short lived frames can be found in the following section. 
 
2005: The High Water Mark 
 
 
2005 represented the peak of overall framing for the period studied. With the Bioethics Council 
documents and parliamentary debates regarding xenotransplantation legislation occurring, 
this provided the greatest volume of framing efforts but also the greatest range of framing 
attempts. 
The Bioethics Council produced both their discussion document and final report on 
xenotransplantation in 2005. This feature, coupled with the encroaching end of the XTP 
moratorium date, prompted Hansard debate on the parliamentary floor; specifically, the three 
readings of the Medicines (Specified Biotechnical Procedures) Amendment Bill debated in May 
2005. The most significant frames usage by volume is found in Figure 3 and Table 1. 
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Figure 3 
Outside of the described major framing efforts, outstanding concerns were seldom engaged 
after the 2005 presentation of Bio Ethics Council documents and parliamentary debate 
regarding an extension of the existing moratorium. There are different factors with possible 
correlative relationships, which could help explain this including: the lack of evidence related 
to risk is matched with the perception of adequate safeguards which undermined outstanding 
ethical concerns - such as public consent, third party risk or animal rights; the shift of issue 
context due to successful framing or current events; the change in government lead to the 
disestablishment of The Bio Ethics Council - the primary source of counter framing; the lack of 
media interest or investigation i.e. the reliance on pre-packaged press releases that featured 
human interest stories; and the lack of public awareness and understanding of public policy 
development in general but also biotechnological development outside of their immediate 
concerns e.g. diabetic support groups and those on organ waiting lists. 
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Frame Number of Instances 
  
Safe Guard 409 
Risk Medical 382 
Hope Medical 294 
Culture 266 
Victim 231 
PUS 162 
Risk Benefit 145 
Problem 144 
Animal rights 135 
Table 1 
 
What is notable from the table of dominant frames is the surprising lack of expected 
archetypical frames. An issue such as XTP lends itself readily to such interpretations as: Mad 
Scientist, Pandora’s box, and Frankenstein’s monster. The Pandora’s Box and Mad Scientist 
frames were only used three times respectively during Hansard debates. For the latter, its use 
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was to specifically point out that New Zealand scientists are nothing like this analogous 
construct e.g. I do not think there are any mad scientists in New Zealand.213 
Interestingly, the Good-Guy-Scientist frame arose in 2005 to exemplify that New Zealand had 
well trained and respected scientists. This was often coupled with the Risk-Benefit frame, which 
suggested or argued that these scientists would leave New Zealand in favour of other countries 
less burdened by intervening bureaucracy. 
Labour [political party then in government] can pontificate about the cultural issues and 
sensitivities, yet people are waiting for life-changing treatments. We need to trust the 
scientists, who are very careful, sensible, and ethical in the work that they have done and 
are doing. We know that the moratorium will not stop the work being done. It will just 
send our scientists offshore so that the work can be done there. Is it any wonder that we 
are seeing a brain drain of scientists right now? There are simply too many hurdles and 
barriers in their way when it comes to New Zealand science to do leading-edge work.214 
Then there was the inaccurate use of framing in 2005; whether intentionally or by 
ignorance, two framing attempts were prominent in their misrepresentation of the issue. The 
Green Party sponsored the Prevention frame during Hansard debates, saying that we should be 
taking action to prevent individuals from needing the sorts of treatments xenotransplantation 
can provide, e.g. by promoting healthy eating and exercise. 
[I]nstead of looking at doing something as radical and with such political risks as  
xenotransplantation, why do we not look in the first instance at the causes of diabetes and at 
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some simple steps that we as a population could take, which are right under our noses, to try to 
prevent diabetes or reduce the epidemic of diabetes?215 
This frame ignored vital pieces of information.  Firstly that Diabecell was being offered as a 
solution to type one diabetes, not the obesity-related type two diabetes. Secondly, this frame 
ignored that an increase in organ donation (the other preventative approach furthered by the 
Green Party) would not meet demand for organ and tissue sources now or in the future as seen 
by Spain's highly successful but still inadequate organ donation policies.216 In both cases, 
prevention is not a solution for those suffering from these conditions. 
Representatives of the political right also sought to direct framing in ways that did not 
accurately describe how their position would resolve the debated concerns. 
We have volunteers who have sought information themselves, and who have consented, 
voluntarily, to the treatments, and to the research that they have undertaken, and they are well 
aware of the consequences of their actions. They know that there are risks associated with the 
treatment, risks associated with research, and, in fact, there are risks associated with life. They 
take this on board and they make a voluntary, conscious decision to participate or to not 
participate.217 
This focus on xenotransplantation being a personal choice between Doctors and patients 
actively side-stepped the issue of third party risk as well as concerns regarding adequate 
public consultation that had dominated concerns up to this point; and, included in the 
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positions of all the major political parties. Their use of the Government Intervention frame in this 
context undermined the potential risks to third parties - such as family, sexual partners and 
medical personnel not engaged within this context. 
What is significant about these short lived framing attempts is that they did not gain 
salience outside of their immediate sponsors or context, which itself became a dominant 
feature of this discussion. As mentioned in Chapter 2, those who use conflicting frames will 
labour extensively to find and build upon common ground, while frame cohesion lends itself to 
productive discussion. Frame usage was consistently used or attributed directly to frame 
sponsors, producing many short lived and conflicting framing efforts. Despite a change in 
government in 2008 there is no evidence to suggest a shift in government sponsored framing 
efforts. Dominant framers in government and industry were able to continuously frame 
xenotransplantation as their role, as key stake holders and their close relationship with the 
media meant they were able to direct the line of framing through event-driven press releases 
which other frame sponsors appeared unable to replicate. 
Initially this meant while the risk of xenosis was considered unknown, Risk-Medical was 
coupled with Safeguard framing – dominating this initial stage of the xenotransplantation 
discussion. Once the issue of endogenous retroviruses were seen to be of minimal or 
manageable risk and it was deemed by the major stakeholders that appropriate safeguards 
were in place, these frames declined in use giving way to the increased use of the Hope-Medical 
and Hope-Benefit frames. 
After the moratorium expired and Diabecell trials were able to resume, central government 
no longer featured predominantly in the xenotransplantation discussion. LCT, as the main 
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sponsors of Hope-based framing efforts, was able to dominate post-2006 xenotransplantation 
discussion through numerous press releases. 
While counter framing attempts remained, these were very seldom engaged; instead, they 
were often presented alongside but not directly referenced by the more dominate frames. This 
however, is a logical step in framing. Once framing dominance had been achieved, any 
engagement with counter framing would only serve to legitimise opposing concerns. 
A notable exemption from this is the presence of the Public Consent frame which featured 
sporadically from 2005-2008. While this was never a dominant frame, LCT did feel the need to 
respond. This issue arose in response to third party risk and the perceived need for a measure 
of public consent. LCT argued this matter had been resolved by The Bioethics Council. This is 
despite that was not the mandate of the Bioethics Council, nor discussed in their published 
documents. Instead, by using the Safeguard frame to argue that The Bioethics Council had been 
a part of rigorous safeguards, this minimised public consent - an ethical concern - by 
refocusing on safety measures, placing the discussion back into a risk -based cost/benefit 
discussion. 
The defining events of the xenotransplantation discussion were the Hansard debates 
regarding the one year extension of the moratorium, and the presentation of the Bioethics 
Council’s findings. This is the key time where overall framing efforts peaked, were some 
frames were discontinued in some cases, or began to rise. 
One notable case of how this changed affected issues was the initial concern regarding 
xenotourism. Xenotourism is when people travel outside of their country to have 
xenotransplantation. Prior to 2005 xenotourism was viewed in regards to Risk Medical and was 
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used in this regard by those who thought New Zealanders would go to other countries - where 
it was argued or implied there would be less stringent safeguards regarding XTP – and pose a 
risk to the New Zealand public upon their return. This was used by those who were concerned 
about the risk of xenotransplantation and those who argued in favour of XTP in New Zealand; 
so it could be done to New Zealand medical and ethical standards. 
After 2005 however, xenotourism was no longer framed as a risk, after the expiration of the 
moratorium. Instead introducing XTP was viewed as a potential economic gain; 
xenotransplantation would now bring xeno-tourists to New Zealand to undergo the operations 
here - coming under Hope-Benefit framing. 
In summary, the major stakeholders dominated public debate. Through their press releases 
and close relationships with news media they were able to consistently create news and frame 
it to their choosing. Prior to 2005 there were a greater variety of frames, yet the processes of 
government debate and the Bioethics Council's final report substantially reduced the number 
of frames after this time. The Chapter 6 will explore this in greater detail - putting this analysis 
within the context of the public engagement of science, as well as other ideas explored within 
the Literature Review, Chapter 2. 
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Chapter Six Discussion 
 
Main Findings 
 
This chapter analyses what implications the discussion of xenotransplantation has for the 
public engagement of science in New Zealand. This places the discussion and the previously 
mentioned trends in context, as to present a better picture of the successes and failures of 
those framing efforts. 
The first section illustrates how the main framing efforts achieved salience; in essence, that 
the major frames formed a basic cost/benefit argument - shaping which frames did or did not 
gain salience from their lack of inclusion into the binary focus. Then it is contended this 
cost/benefit discussion framed not just the issue but the debate; that while 
xenotransplantation was being discussed, the larger issue of biotechnology in New Zealand 
society and in particular Maori culture and biotechnology, was explored and presented to the 
public. 
In addition to this, an examination of how uncertainty and risk became some of the most 
interesting factors of the public deliberation, and how this conversation has shaped the social 
contract between the biotechnology industry and the New Zealand public. 
The main findings of this research are that there was a logical reduction of narrative based 
upon a meta-framed cost/benefit analysis, and that this was achieved through persistent 
framing efforts by key stakeholders - combined with an emergent perception of low risk and 
New Zealand's safeguard standards. The extensive use of the Risk-Medical frame ensured 
xenotransplantation had a risk assessment attached to it. Yet this risk was overwhelmingly 
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presented as low and manageable, especially as it often coincided with the use of the Safeguard 
frame. 
2005 represented the peak of framing efforts with the Hansard debates regarding the 
extension of the moratorium and the presentation of the Bioethics Council’s discussion and 
findings documents. Afterwards, the expiration of the moratorium meant trials were able to 
proceed and Living Cell Technologies (LCT) was able to frame extensively. This was furthered 
by content sharing through the New Zealand Press Association, which produced near-identical 
articles in regional and national newspapers - bolstering nationwide issue framing.218 Post-
2005, Safeguard framing exceeded Risk-Medical which had begun to decline, whereas  
Hope-Medical remained steady and the use of Hope-Benefit framing grew. 
As mentioned in Chapter 3, episodic framing is often used by news media - as it can produce 
personal and emotive storytelling. Episodic framing was effectively used by LCT, as the 
company was able to frame itself as positive and relatable. More than presenting itself within 
an economy of hope by focusing on the potential medical and financial benefits of 
xenotransplantation, the recurring frame of Govt-Interference from 2009-2010, and the 
introduction of the Grass-roots frame, conferred a relatable persona.  This was personified by 
Director, and Chief Science and Medical Officer, Professor ‘Bob’ Elliot. Professor Elliot’s cultural 
rapport with the New Zealand audience was achieved though emulating language and cultural 
archetypes of New Zealand; such as the pioneering spirit, hard work and ‘the underdog’. This 
can be seen in the exchange below: 
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 Q: What has been the biggest obstacle in running your company? 
A: (Professor Elliot): The regulatory procedures […] You’d be amazed at the mountain of paper 
generated to get through this xenotransplantation thing and thousands and thousands of hours 
have gone into getting regulatory approval. 
 Q: Why did you keep going? 
A: I was not going to let the bastards grind me down. Nothing was going to stop me, nothing, and 
if it requires thousands of hours, then I will find those hours.219   
This approach positions and shapes the emotional reaction to one of the main stakeholders 
in the xenotransplantation debate in New Zealand. This reduces the context given to XTP in 
New Zealand and abbreviates medical and ethical concerns into an embattled underdog facing 
an intrusive and obstinate regulatory system. As mentioned previously, this framing, by and 
of, LCT took place when counter framing and the Risk-Medical frame in particular was in steep 
decline, meaning there were few dissenting voices to an otherwise sympathetic stakeholder. 
This underdog status is also relevant to New Zealand’s self-perception in contrast to 
Australia, whose geographical proximity and shared heritage has fostered a friendly but 
culturally significant rivalry. As described in Chapter 2, countries such as Iceland and Tonga 
were able to draw from ethno-nationalism in support of their biotechnology ventures. New 
Zealand did this in a certain manner by focusing on the potential of the Auckland Island pig 
population through the Pharma-Pig frame, but more prevalent was cultural insecurity. 
The extensive use of the Risk-Benefit frame - a frame primarily used to highlight the risk of 
economic loss or missing out on the expected biotech boom, was used extensively prior to 
                                                             
219 Rotherham, Fiona, CELL SCIENTIST DETERMINED, The Press (Christchurch, New Zealand), p. 21 – Data set, 
Factiva, subset 4, p. 9 
90 
2006. Risk-Benefit played a significant role in the case for xenotransplantation in New Zealand – 
through the often implied or inferred notion that LCT would move operations overseas, likely 
to Australia, in response to supposed regulatory hurdles in New Zealand. This was a salient 
point for the New Zealand audience, hence its popular usage. 
  
The Logical Reduction of Narrative 
 
The research showed the major frames produced a meta-framing effort that constituted a 
cost/benefit analysis, restricting what was considered acceptable approaches to the issue of 
xenotransplantation in New Zealand. Cost/benefit analysis is a persuasive method of thinking, 
as it is often presented as a fair and forthright mode of analysis and decision making, but its 
use in public policy has numerous drawbacks. The first of which is that cost/benefit analysis 
does not identify the population segments whom the proposed measure would benefit or 
harm.220 
When discussing the benefits of a successful xenotransplantation research program, New 
Zealand was described as gaining from this development as if it were a monolithic entity, with 
few specifics being given by frame sponsors in government or industry as to who were to gain. 
Initially, as Diabecell became the focus of the debate, diabetics became a specific group 
which was singled out as one that would benefit, but with no specific information or proposed 
ideas anywhere in the dataset about the pricing of Diabecell, or its place in the public health 
                                                             
220 Dorfman, Robert. Rothkopf,  Micheal H., Why cost benefit analysis is widely disregarded and what to do about it, 
Interfaces, Vol 26, no 5 1996, p. 1-6, URL jsot.org/stable/25062162 
 
91 
program. In light of this there is no assurance that diabetics at an economic disadvantage will 
not receive a lesser standard of care despite their use in framing efforts. 
Yet while benefits were framed in more general terms, risks were framed in a way that 
localised concerns and minimised third party risk and, by proxy, greater public engagement. 
Initially, when the evidence of retroviral infection was discovered and reported on in the 
Lancet documents, fears over the possibility of an epidemic was widely reported. This concern 
provoked numerous references to, and statements about, New Zealand’s laboratory and 
regulatory safeguards - which continued until the decline of the Safeguard frame in late 2008, 
after observing a brief resurgence in response to the Swine-flu epidemic. This effort, and the 
lack of corresponding research showing retroviral infection by xenotransplantation, saw 
generalised Risk framing itself, decline steeply after 2005. 
As tool for public policy, cost/benefit analysis’s efficacy can also be challenged on the basis 
it attempts to reduce all comparisons to a single dimension.221 The segregation of public 
discussion of biotechnology is most apparent with Maori, where Maori opinion was regarded 
as value and culture based, denying its input in intellectual or scientific conversation and 
placing it aside or in perceived opposition to scientific conversation. Activist Ken Mair said in 
relation to Maori input in the biotechnical discussion, that the issues raised were ‘more than 
cultural’ and that they are at an intellectual and scientific level. […] We are tired of being relegated into 
some subservient little box called ‘cultural understanding’.222 
This is also made apparent by the mandate given to the Bioethics Council, of seeking public 
views on the cultural, spiritual and ethical aspects of the technology while the Ministry of 
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Health reviewed its safety. It was, and remains, a clear demarcation of where public input is 
asked and where it is unwelcome. This enables a false equivalency - where the issue is framed 
in terms of the mutually reinforcing scientific and economic rationalities, juxtaposed by Maori 
value assessments. This juxtaposition presents different viewpoints as being equal in societal 
value assessments, when this is not the case. For example, human rights are by their virtue 
non-negotiable if compared to economic considerations, but placing them side-by-side would 
not present this difference. 
Cost/benefit analysis, even on this meta-scale, is significantly reductive in its presentation 
of community ideas and positions. This can generate social tension by not presenting the 
diversity of Maori and European views. This can be especially damaging as the cultural 
concerns of Maori are routinely portrayed as a significant obstacle for scientific and economic 
progress.223 Not only does this undermine Maori voices in scientific contexts but also means 
that cultural and ethical concerns in general are undermined by the binary discourse, 
depriving the conversation of nuances that could make for better policy outcomes. 
What is crucial is that an informal cost/benefit analysis represents a measure of what a 
society values by how it assigns value within this analytical method. It should be used to 
provide information relevant to the decision-making process - not make the decision itself as 
logical reductions of narratives do.224 Further, any decision a cost/benefit analysis facilitates 
still rests on all existing values of society; as a method, it doesn’t ignore, generate or develop 
values but its application can create bias.225 So when cultural and personal values are discussed 
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in this context, it means that the myriad of Maori and Pakeha cultural interpretations were 
reduced to the ‘cultural and spiritual issues associated with the procedure’ against an economy of 
hope.226 
This is a core weakness in how binary discourse weakens public policy development by 
reducing public input. It lends itself to an economic model where there are clear values that 
can be incorporated into the decision-making process. Despite this, cost/benefit models do not 
presume a decision, but to facilitate them. This is why in research where the public has been 
questioned by cost/benefit analysts on how much they would be willing to pay to save a 
particular wilderness environment or specific species, these questions commonly go 
unanswered.227 As value assessments are heavily subjective, they cannot be adequately 
measured against each other or economic factors. This increases the likelihood of controversy 
or stalemates that result in policy that doesn't fit the communities it was designed to serve. 
As mentioned in Chapter 2 it was a common complaint, from those involved in public 
engagement of science events, that many of the starting points of discussion or supporting 
information were presented without background information on how a certain position, 
conclusion or risk assessment was achieved. It was simply presented as part of a public 
engagement of science effort that repeated the assumptions of a deficit model of public 
understanding. This focus on process from the public points to one of the key elements of the 
scientific method in that a position requires a defence of argument or evidence – serving as 
testament to the public’s ability to engage actively with science, in areas not specific to value-
based argument. 
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Such an approach can be used to conceal degrees of inaccuracy or uncertainty in estimates - 
risking the possibility of audiences forming conclusions from misleading information and 
directly affecting their buy-in to the economy of hope. In the context of the XTP debate, the 
degree of accuracy in the presented risk assessments were not specified in the print media, nor 
the discussion documents produced by the Bioethics Council or the background documents 
supplied to Members of Parliament. Instead, the risks were consistently portrayed as 
extremely low, with uncertainty or variation of risk assessments undisclosed and in 2007 LCT's 
Professor Elliot went so far as to reassure the public that: ‘the move [to stop trials] had been purely 
precautionary because of limited research suggesting that pig retroviruses could infect patients. Now we 
are confident that this isn’t the case. After more animal studies and carefully following patients for more 
than a decade, the scare has gone.’228 
 
Uncertainty, Risk and Public Deliberation 
 
The inability to recreate the original Lancet studies was at the centre of the initial low risk 
assessments that were an integral part of the xenotransplantation debate in New Zealand. This 
meant that early in the public debate risk assessments concerning xenosis were consistently 
low. However more recent information presented in Nature and reported in New Scientist, 
undermines this assumption and has far-reaching consequences for biomedical science as a 
whole.229 Two large pharmaceutical firms independently revealed they could not reproduce the 
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vast majority of published studies.230231232 Yet, such studies remain an important tool for 
alleviating the financial burden for proof-of-concept, that work towards providing new and 
better treatments. 
In September 2011 Bayer Healthcare revealed they had performed an in-house survey of 67 
projects and found that only in ~20-25% of the projects were relevant published data completely in line 
with [their] in-house findings.233 Further, that the reproducibility - or lack thereof – did not 
significantly correlate to journal impact factors, the number of publications on the respective target or 
the number of independent groups that authored the publication.234 
Soon after, another company and rival of Bayer, Amgen, reported even higher levels of 
failed reproducibility trials. They showed that in their effort to reproduce 53 landmark cases, 
only six cases were a success - a failure rate of almost 90% - despite knowing the limitations of 
preclinical trials, this was a shocking result.235 They responded that given the inherent difficulties of 
mimicking the human micro-environment in preclinical research, reviewers and editors should demand 
greater thoroughness.236 
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It is important to make clear that this does not mean, as was often inferred at the time, that 
90% of science cannot be reproduced.237 It does mean however, that a greater level of 
uncertainty needs to be acknowledged, especially in the preclinical stages. For the 
xenotransplantation debate, the certainty in which the economy-of-hope was deployed, the 
low risk assessments should have been tempered considering the apparent long-time 
knowledge of unreliable preclinical trials and, as the researchers from Bayer argued, this non-
reproducibility indicates the limitations of the predictivity of disease models.238239 This revelation 
should temper how biomedical technology is introduced and understood, how benefits are 
marketed, and how risks are presented to the public. 
A large part of the reasons for preclinical trials is to prove the safety and efficacy of 
treatment before it reaches the public, yet for the XTP debate, it reinforced the authority of 
LCT’s risk assessment, where the non-reproducibility of The Lancet studies became the basis 
for communicating low risk; a designation that was commonly used, seldom explained and not 
completely accurate.240 
While uncertainty was not attributed to any risk assessment by the major stakeholders, in 
December 2010 there was the short-lived introduction of the Not-a-Cure frame – used to temper 
the expectations of Diabecell within the economy of hope. Though LCT and others in the 
scientific community were generally responsible in the description of what Diabecell could 
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mean as a diabetes treatment, those in the media, or victim advocates, often inferred greater 
and sometimes misleading conclusions. This led to statements such as 
Medical researchers have successfully treated diabetes in laboratory monkeys by transplanting 
pancreatic tissue from pigs – giving hope that pig transplants may one day be used to cure 
childhood diabetes in humans.241 
And: 
 Xenotransplantation has been advanced a potential cure for a number of serious health 
 concerns, including diabetes and Huntington’s disease.242 
This was understandable misreporting of the immediate potential of xenotransplantation - 
media sensationalism can easily misinterpret statements regarding clinical trials, what is 
hoped to be achieved by them and what successful trials might mean for the future of 
xenotransplantation. However the misrepresentation of xenotransplantation as a cure for 
diabetes is not entirely the fault of a scientifically naive media. Professor Elliot, in arguing the 
benefit–risk threshold had been crossed, stated [animal trials] had demonstrated the efficacy of pig 
cell transplants. Fifty percent of mice are cured with the treatment: ‘Crikey, any treatment that can cure 
at least half of any condition, you’d want that, wouldn’t you?’243 
This idea that xenotransplantation - specifically Diabecell - would provide a cure, became 
pervasive amongst the mainstream media. In May 2008 it forced Minister of Health David 
Cunliffe to respond: 
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I want to make it clear to New Zealanders that while the application is for a clinical trial  
involving only 8 diabetics subjects, there are risks associated with this not only for the subjects 
but also for the wider public. Unfortunately […] diabetes sufferers were led to believe that a cure 
for the disease was being withheld from them. Nothing could be further from the truth as this 
clinical trial is not offering a cure. Quite apart from misrepresenting my position, I am appalled 
that [the media] has misled the public on this very serious matter.244 
This expectation within the economy of hope, fostered by inaccurate reporting from 
industry and the media, placed significant public pressure on the government to allow 
xenotransplantation. That it became the responsibility of government to address the 
inaccurate expectations is a damning representation of LCT and a scientifically illiterate 
media. It was not until clinical trials resumed, that LCT made a concerted effort in 2010 to 
temper the expectation that Diabecell was a treatment for diabetes rather than a cure. 
The scientific community is often presented as offering definite predictive knowledge on 
the consequences of new technologies in the form of institutionalised risk assessments. Yet 
those involved in their production are frequently exonerated from responsibility if there are 
negative consequences, as scientific knowledge and its predictive qualities are also accepted as 
provisional.245 As the risk assessments associated with new biotechnologies factor strongly in 
the arguments and conclusions about disease models, safeguards and response, greater 
accountability is required to make future discussions more transparent and equitable. The 
                                                             
244 New Zealand Government Press release, A proper process for xenotransplantation, 21 May 2008, Scoop.co.nz  
245 Waterton, C, Wynne B E, Grove-White, R.B., and Mansfield, T., Scientists reflect on Science: scientists’ 
perspectives on contemporary science and environmental policy, A research report by the Centre for the Study of 
Environmental Change and the Institute for Environmental and Natural Sciences, Lancaster University, Lancaster 
2001, URL: www.csec.lancs.ac.uk/docs/Waterton_SROS_report.doc 
99 
current format has in effect silenced the public side of the debate not directly related to value 
based arguments as the provided information is given as fact as opposed to expert opinion. 
This makes the same false assumptions as the deficit model discussed in Chapter 2. 
Scientists, experts and scientific discussion are often seen as unbiased and drawing direct 
conclusions from clear data - in this case a low risk assessment, while public input is presumed 
to be value-based, which holds less significance and credibility in intellectual discussion. 
Important to this discussion is timing. As mentioned previously, in 2005, the Bioethics 
Council produced a discussion document on xenotransplantation and preformed a number of 
public deliberation meetings and Hui in major centres in New Zealand.  Later that year the 
Bioethics Council presented their conclusions to the New Zealand government. 
Its mission was broad: to consider the ethical, cultural and spiritual issues connected to 
XTP. Yet it was not until 2008 that the Minister of Health ordered an investigation by the 
National Health Committee into LCT’s application for clinical trials.  
This meant Bioethics Council researchers and the public who took part in the public 
deliberation, were not in a position to make their submissions with access to an independent 
scientific examination of LCTs information. One main reason being that clinical trial 
applications were not being accepted by the Ministry of Health in 2005, because the 
moratorium was still in place. Considering that scientific and value based arguments were 
segregated, it is intriguing that ethical considerations were so far removed from the 
independent risk assessment provided by the NHC, and that it was not deemed that ethical 
considerations would need to be publically re-examined in light of this new risk assessment. 
100 
As part of the clinical trial review process, the NHC did take public submissions which 
included written and oral submissions and public meetings in major centres.246 This was a 
commendable effort, but the submission process did not allow for the NHC's independent 
review as it was for the application for clinical trials and xenotransplantation in New Zealand – 
not as a response to the findings of the NHC review. 
In essence, there was a lack of public space for the review of the new information brought 
forward by NHCs risk assessment and their procedural recommendations. This included issues 
the public would have strong interest in, such as non-patient involvement; such as life-long 
monitoring of the patient’s intimate partners not involved in the original consent process, and 
the issue of long term liability in the case of PERV infection - which the NHC acknowledged as 
unresolved.247248 
Despite this, the NHC used the Bioethics Council consultation as the basis for their 
conclusion that the ethical considerations had been adequately considered - a key factor in 
their overall recommendations to the Minister of Health.249 The NHC had to consider as part of 
the application review process, that ethical issues ‘raised by the conduct of the procedure or class of 
procedure to which the application relates and by any technology involved in that conduct have been 
adequately addressed.’250 Yet upon examination of LCT’s submission towards that specific 
criterion that put forward these definitions: 
 That ‘adequately’ is a low threshold, which only requires that these issues be addressed in a way 
 that is ‘barely sufficient’. 
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And, 
 That ‘addressed’ does not mean these issues need to be resolved or that people with concerns 
 need to have consented to the trial, only that such issues have been ‘considered and 
 acknowledged’.251 
While the NHC took exception with the qualifier of ‘barely’ before the word ‘sufficient’ - 
arguing that this made the threshold standard ‘too narrow’, they were satisfied in this response 
to third party concern. Significantly, this third party concern was ascribed almost exclusively 
to Maori: 
 There is an ethical argument that, because the trial has the potential to impact a wider 
 population beyond individual patients, that a form of collective consent is required. For some 
 cultures, such as Maori and Pacific peoples, the requirement for collective rather than individual 
 consent is valued. Such an approach may be applicable to any medical procedure a Maori or 
 Pacific person might undergo.’252   
During the Bioethics Council investigation, Health and Disabilities Commissioner Ron 
Paterson had warned individual consent to xenotransplantation research was insufficient and 
that a method of collective consent was necessary.253 This suggests that the issue of third party 
consent was a valid topic of discussion post-2005, yet it was represented only marginally 
through the Pubic Consent frame - sponsored by a lobbyist for the Sustainability Council.254 
Further, as third party risk and fear of a PERV epidemic featured so heavily in the initial 
discussion and eventual moratorium on xenotransplantation, it is somewhat difficult to 
                                                             
251 Ibid, 22 
252 Ibid. 
253 Stewart Dye, NZ ‘ill prepared’ for pig cell trial, the New Zealand Herald, 4 Oct 2007 
254 Ibid. 
102 
understand the motivation for describing this issue along racial lines. As mentioned before, 
this issue-segregation alienates Maori and non-Maori from open discussion. It presents Maori 
concerns as solely value based and obstructionist, and minimizes the ethical concerns of non-
Maori New Zealanders. 
The opportunity for these discussions is important, as it addresses significant and material 
concerns related to xenotransplantation. In 2008, when asked about further public 
consultation, LCT chief executive Paul Tan referred to the Bioethics Council public 
engagement, saying there was no need for more consultation on the aspect of community risk 
and liability. This is despite the Bioethics Council report showing the public wanted a reliable 
medical authority to declare XTP as not presenting a significant risk to public health and that 
the possible risks could be managed.255 One can only assume that risk assessments in 2008, from 
GTAC and the NHC, would have gone some way to providing this but were unavailable for 
another three years and thus unable to be incorporated into the Bioethics Council public 
engagements and subsequent recommendations. 
The issue of liability is another area that the New Zealand public was unable to provide 
input. The Bioethics Council stated in its 2005 conclusions that liability in the event of xenosis 
would be an appropriate issue for the Law Commission - in the same manner they had 
investigated the concept in relation to genetic modification that led to their establishment. In 
2008 the NHC continues that the issue of liability is unresolved – as LCT does not accept 
liability after five years from the beginning of the trial period. Considering ACC legislation 
would not cover participants in this clinical trial, the NHC recommended participants should 
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have access to liability cover for the entirety of their lives.256 This would likely come at the 
expense of taxpayers. 
So despite Paul Tan and others attesting that public consultation was unwarranted, it 
appears there would be a substantive case for further deliberation if Diabecell, or another 
xenotransplantation procedure, were to continue past Stage Three clinical trials and eventual 
commercial release. 
Public Engagement 
 
In addition to these outstanding issues, the public submission process did not work effectively. 
Public deliberation on XTP, as in general, have low turnout in submissions. This is generally 
attributed to lack of topic interest or general public apathy but this may not be the case. As 
mentioned in Chapter 2 arguments have been made that suggest that if that the public is 
supposedly uninterested, there is little cause to involve them. 
This would seem compelling when public submission processes are dominated by interest 
groups. For the NHC public submission process, 95% of those came from people with diabetes. 
It is clear why: diabetes is a terrible affliction that can substantially affect a person's quality of 
life. As such, the prospect of normality - in so far as reducing the need for insulin and regular 
blood testing - is cause for hope and support. 
This being said, xenotransplantation in New Zealand is an issue that extends past victim 
advocacy, and 95% of submissions being from sufferers or diabetes advocacy is not a fair 
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representation of the New Zealand public that will also take part of the risk of clinical trials but 
also a future in which xenotransplantation may become a regular feature in diabetes. 
Public apathy in the civil engagement has regularly been attributed to ineffective or 
untrustworthy media outlets.257258  This, in combination with how the public sector advertises 
for public submissions, has led to accusations that public input is being actively discouraged by 
how it is presented - in contrast to how the private sector advertises itself.259260261 
This is important, as public submission processes are often in contrast to well-funded 
framing efforts, as seen in the research. LCT, as a major stockholder in the issue of 
xenotransplantation, was able to give itself a regular platform to make its ideas heard and felt. 
Public submission processes have funding provided by governmental organisations such as 
the Bioethics Council and do not have marketing experts working on increasing active political 
engagement to the same degree as private firms advertising for consumer goods. This partially 
explains the relatively poor attendance for the Bioethics Council public engagement sessions 
with the highest attendance of 33 attending the 2005 bi-cultural Hui in Christchurch.262 How 
certain events like public submission processes are reported by the media, can heavily skew 
the information available in articles. In Chapter 2, Allspaw presented concerns of whether 
                                                             
257 Pinkleton. Bruce E., Weintraub, Erica, Media Perceptions and Public Affairs Apathy in the Politically 
Inexperienced, Mass Communication and Society, 2004: 7:3, p. 319-337 
258 Pinkleton, Bruce E., Weintrau, Erica, Yushu Zhou, Austin, Willoughby, Jessica Fitts, Reiser, Megan, Perceptions of 
News Media, External Efficacy, and Public Affairs Apathy in Political Decision Making and Disaffection,  Journalism 
& Mass Communication Quarterly March 2012 vol. 89 no. 1 23-39 
259 Meslin, David, The antidote to apathy, recorded Oct  2010, TEDx, URL: 
ted.com/talks/dave_meslin_the_antidote_to_apathy 
260 Cowan, James, Sending a Message on Posters, National Post,Toronto, 12 October 2002 
261 Levin Laura., Solga, Kim, Building Utopia: Performance and the Fantasy of Urban Renewal in Contemporary 
Toronto, TDR: The Drama Review, 53.3 (2009) 37-53  
262 The Cultural, Ethical and Spiritual Aspects of Animal-to-Human Transplantation: A report on xenotransplantation 
by Toi te Taiao: the Bioethics Council Ref. BC 13, August 2005, The Bioethics Council, Ministry for the 
Environment, New Zealand. 
105 
democratic ideals are better served by, ‘allowing the voices of the concerned and/or informed to rise 
above those of the indifferent and/or uninformed?’263 
As a response to this thinking, urban activist Dave Meslin has become notorious for 
illustrating the differences between calls for public submissions on urban planning, and 
private sector advertisements.264  For example, news media stories related to theatre shows, 
new technology and restaurant reviews were shown to provide clear information on specifics 
such as topic or genre, location, date, time and contact information, as distinct from the story 
itself; presented either before or after the review article. 
Yet in instances in which news articles discuss issues open for public submissions, there was 
little to no relevant information for getting involved in a similar manner to the private sector 
advertising.265 This distinction reinforces the idea that politics and science are distinct from 
everyday life - the strict purview of those in government, industry or special interest groups. 
This idea is furthered by the focus on leaders and episodic framing in these news stories; 
describing leaders in their field and leaders in group advocacy - such as the focus on Professor 
Elliot and his story as an embattled entrepreneur. This undermines the position of the public 
because, when combined with a lack of information in news stories, there is no popularised 
method for community involvement or a local or central government service for the 
dissemination and translation of documents for public consumption and deliberation.  
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While currently only anecdotal, there was very little specific contact or event information 
within the dataset - this may suggest why the Bioethics Council public events received so few 
participants. And while the NHC did take public submissions, they also note that GTAC was 
under no obligation to do that same; there is no requirement that GTAC or the other various 
advisory committees invite public submissions when deliberating on clinical trials involving 
third party risk. There is also no requirement that the information gathering, deliberative and other 
procedures used by these committees be available for public scrutiny.266 Or that the committee has to 
publically approve, disapprove or provide their reasoning to a public audience.267      
The Social Contract 
 
That the authorities tasked with ethical considerations were under no regulatory obligation to 
invite public submission, is concerning. For more than a decade the social contract with 
science had been seen to be renegotiated in a manner which cemented public engagement 
with the scientific community. Prior to this, science was effectively left alone, expected to 
produce reliable knowledge and communicate this knowledge to society.268 This was a 
relationship between the scientific community and the public based, in part, on trust. 
Yet in recent decades the relationship between university, government and industry labs 
has become more intertwined.269270 As a result of this, pressures to produce objectives or real-
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world application of science rose.271 For some in the public sphere this interconnectedness and 
focus on the scientific ‘product’ was cause for concern. 
As observed in Chapter 2, Murphy showed that the assessments of nicotine addictiveness 
shifted dramatically depending on the associations of the science team.272273 In 2001 the Royal 
Commission on Genetic Modification specifically mentions the concern the New Zealand public 
held regarding the motives and trustworthiness of scientists. Quoting Dr Roger Wilkinson, the 
report says: 
 People don’t trust genetic engineering. […] They also don’t trust genetic engineers. Some groups 
 described how scientists have let us down too many times […] The Industry group observed the 
 lack of trust in proponents. […] Scientists were described in the Opponents group as arrogant […] 
 Biotechnology companies were being described as being interested only in profits: […] Someone in 
 the Provincial group even suspected a conspiracy. […] Motives of the scientists were regarded as 
 important, along with the source of their research funds and who their employers were.’274 
    Considering the opinion of the New Zealand public at the time, it is perhaps unsurprising 
that their recommendation for the establishment of the Bioethics Council was taken as 
seriously as it was. In New Zealand this represented a sea-change in how biotechnology was 
presented and marketed to the public. The Bioethics Council sought public consultation on 
issues from genetic modification, xenotransplantation, human assisted reproduction and 
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Maori responses to biotechnologies. Interestingly, in quotes from the public the Bioethics 
Council chose to display, the suspicion of scientists, apparent in the RCGM report, is absent. 
Instead of questioning the scientist’s motives, the quotes question their science or their ability 
to speak on values issues. 
The reason for this is not entirely clear. The apparent openness of modern science is likely 
to have been a significant factor, or that biotechnological research is pointed to becoming a 
successful industry; or perhaps, because of the very palpable diseases and needs that 
xenotransplantation could provide solutions for. In its most basic form, xenotransplantation 
can be considered a simple solution for a simple problem i.e. replacing broken body parts with 
comparative body parts. As such, the benefits and motivations appear to be clear; in contrast, 
the rationale and application for genetic modification are diverse and therefore more open to 
interpretation or audience bias. 
Issues with Balanced Discussion 
 
The narrative formed by the overarching discussion formed a meta cost/benefit analysis. Ideas 
of an ethical nature, such as ‘Should the New Zealand public have to give a form of collective 
consent?’, do not fit neatly into either category and like Maori cultural concerns, were viewed 
as obstructionist, or that they should be left to ethicists to discuss amongst themselves. 
The apparent risk of losing New Zealand’s competitive advantage, or that time spent 
discussing these issues came at the cost of lives, helped reinforce this concept within the 
debate. For this reason, the debate is relatively streamlined - ethical or value concerns never 
gain salience. Despite the remaining unresolved issues, the prospect of medical advancement 
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and economic gain overshadowed other apparently less salient concerns and thus dominated 
the public discussion. 
Additionally the separation of Maori and Pakeha voices came under inspection from the 
Bioethics Council. In their reflection on the dialogue process, the Bioethics Council identified 
the interactions between Maori and Pakeha at the bicultural Hui as a highlight.275 They 
mention a particular Pakeha woman who spoke about European New Zealanders perhaps 
lacking the language to express cultural or value based ideas - which for her, identified an area 
of potential community growth.276 
The same sentiment was expressed in the Bioethics Council’s reports suggesting that such a 
cultural exchange allows Maori and other New Zealand communities to explore the diversity 
of their perspectives.277 
This chapter has illustrated that the public discussion of xenotransplantation was shaped by 
elite framing by government and industry. This effectively shaped the national discussion into 
a cost/benefit analysis which maligned Maori cultural and spiritual concerns as obstructionist, 
while denying these same concerns to non-Maori New Zealanders. 
The result was a logical reduction in narrative - where medical and economic hope was 
largely contrasted against cultural concerns; after xenosis risks failed to materialise, and over 
a decade of public reassurance regarding the standards of New Zealand laboratory and clinical 
trial standards, the economy of hope won-out over concerned communities delegated solely to 
cultural consultations. 
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This meta cost/benefit frame overlooked some considerable concerns - such as third party 
risk, liability and equitable access to this technology. Additionally, the manner in which the 
New Zealand public was invited to partake in the submissions process actually inhibited public 
access through a lack of visibility and desirability. The continued inability to rectify this 
situation undermines the democratic ideals that are the foundation of a negotiated social 
contract - without which, the support of the public will inevitably erode, making science and 
technology sector in New Zealand an industry labouring under a context of fear and suspicion. 
Chapter 7, the final chapter, will review the findings presented here and place them within 
the greater context of the public engagement of science. It will also review the research, 
describe its limits, discuss the situation as it stands, and how this can spur further research in 
this area. 
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Chapter Seven – Conclusions 
 
This research was designed to assess the evolution of the xenotransplantation debate in New 
Zealand from 1998 after the first and only reports of xenosis infection of human cells, the 
moratorium on xenotransplantation and onwards to 2013. This was done in order to observe if 
the shifts in public discussion were a key feature that contributed to xenotransplantation’s 
legal and ethical status within New Zealand. In order to analyse this debate, a frame analysis 
methodology was used to track the most significant themes and issue stakeholders. As 
expected there was a distinct framing effort from the political and industrial elite that 
dominated the description of xenotransplantation and the issues that surrounded it. 
Unexpected however was the clear manifestation of cost/benefit narrative that arose from the 
dominate frames. 
This occurred as the framing elite were able to consistently sponsor favourable frames 
through press releases, episodic framing and event driven content. After the Therapeutics and 
Medicines Bill had been debated and the Bioethics Council had presented their final report in 
2005, counter framing efforts declined dramatically. The previous varied ethical concerns, 
many of which remain outstanding, became collectively referred to as “ethical considerations’. 
From 2005 these ethical considerations were deemed, according to its framing, as effectively 
resolved. This designation did not acknowledge that many legitimate issues had yet to be 
explored by the law. A key issue in this context is liability and extended risk; as it stands Living 
Cell Technologies only accepts liability of its patients for five year after the completion of 
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clinical trials.278 Of further issue is that current ACC legislation would not provide cover for 
those affected by xenosis.279  The NHC recommended that the Minister of Health refer this issue 
to the Law Commission, as of the time of this research is being submitted there has been no 
publically released information to state or suggest this issue has been resolved. 
The ability to reasonably assert that the cultural, ethical and spiritual concerns had been 
observed through the Bioethics Council’s public consultation sessions was a powerful factor in 
facilitating later reviews by the Gene Technology Advisory Committee (GTAC) and the National 
Health Committee (NHC). As part of these assessments these institutions had to ensure that 
ethical and cultural concerns were consistent with the current legislation. GTAC and NHC both 
invited public submissions that were dominated by victim’s advocacy, and the Bioethical 
Council’s public engagement sessions were poorly attended. This suggests that the public 
engagement of science (PES) in New Zealand requires a reassessment in the efficacy of its 
submissions processes and the recruitment of public interest. 
As outlined in Chapters 2 and 6, the idea that the largest challenge to public involvement is 
apathy is misleading. Increasing the focus on public relations and media presence of issues and 
contact information would substantially bolster the public submissions process. The 
importance of the public submission process should not be underestimated. Firstly, the use of 
biotechnology in the day-to-day experience of the public has increased and as such the ethical 
concern that sufficient consultation is undertaken has been coded into law. And secondly, 
there is the renegotiation of the social contract between science and the public; this 
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acknowledgement of the public’s place in science allows for a more stable environment for the 
biotechnology industry and informs robust policy formation. 
What exactly is the public place in scientific development was explored in chapter five. 
There was the distinct concern about the lack of space for public submission not directly 
related to cultural concerns. Maori activists expressed the feeling amongst Maori that their 
opinions were limited by labels of cultural and spiritual concerns and argued their 
contributions were also at an intellectual and scientific level. This segregation of values and 
intellectual debate often posited Maori as being obstructionist, holding back scientific progress 
due to cultural apprehensions. 
This heavy focus on Maori culture and the assumptions of value bias did not adequately 
represent the diversity of Maori opinion. This sentiment though, should not be limited to 
Maori. The general public as a whole is consistently confined to value based arguments and as 
presented in Chapter 2 the negative bias by those in industry hold towards personal narratives 
and values arguments is high. Yet the same study shows promise for growth as Cuppen et al. 
describes that scientist evaluated public claims higher than industry experts when they were 
not forced to, in the words of Cuppen et al., activate a stereotype of an emotional, irrational public. 
This stereotype meant that the lack of a definitive risk positioned cultural and ethical 
considerations against medical and economic hope. This formed the basis for the logical 
reduction of frames towards a more simplified cost/benefit analysis. This cultural 
reductionism produced rational conclusions about the future of xenotransplantation, being: 
that under the right supervision and appropriate safeguards there is little reason as to why 
those practicing xenotransplantation should be hindered in their efforts towards providing 
cures and treatments for a variety of sickness. This may represent a fair balance of risk and 
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benefit, yet the manner in which this conclusion was reached discounted the variety of ethical 
and cultural concerns and did not allow for the inclusion of the NHC's independent risk 
assessment. Despite this, the public discussion was used by those in government and industry 
to assume the mandate to further xenotransplantation development. In light of this there is 
little doubt the manner in which XTP was framed affected its current legal status by using the 
machinations of public engagement without the sincerity that a timely independent review 
was produced and presented to the public in a transparent manner and allowed for the 
desegregation of scientific and ethical discussions. 
 
The Current Legal Status of XTP in New Zealand 
 
Xenotransplantation is currently a restricted procedure and is regulated as a “specified 
biotechnical procedure” requiring the approval of the Minister of Health and is expected to be 
in accordance with “Good Clinical Practice” standards.280 This became the legal status of 
xenotransplantation after the expiration of the Medicines (Specified Biotechnical Procedures) 
Amendment Bill in 2006 that briefly extended the moratorium of this procedure. In the 
unlikely event of a xenosis emergency the Medical Officer of Health has the power to 
intervene. This responsibility incorporates intrusive response such as forceful quarantine and 
                                                             
280 Ministry of Health Inquiry into Improving New Zealand’s Environment to Support Innovation though Clinical 
Trials: Response to Health Committee request for information: System framework for considering applications for 
approval of clinical trials, Ministry of Health, New Zealand, Report No 4, 2 August 2010 
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retrieval of biological samples as outlined in the Law Reform (Epidemic Preparedness) Bill 
2006.281  
During the debate the Bill’s implications for rights and freedoms affirmed in the Bill Of 
Rights Act were defended by the Honourable Pete Hodgson, then Minister of Health, saying: 
The rights of people in our communities have to be weighed against individual rights. The bottom 
line is that people in our communities deserve a good degree of protection from being 
unnecessarily infected with a dangerous disease, so some of the measures in this bill will infringe 
on the personal liberties of some individuals in order to prevent them from unnecessarily 
infecting others.282  
This position is warranted by the provision within the Bill of Rights Act, Section 5, which 
absolves the Medical Officer in breaches of the act so long as they can be demonstrably 
justified in a free and democratic society.283 The NHC considers the current legislation as 
providing the appropriate capacity to respond to the infectious disease risk.284 
 
 
 
                                                             
281 Law Reform (Epidemic Preparedness) Bill, 2006 No 39-2, Supplementary Order Paper 2006 No 82, Explanatory 
Note, p. 2 
282 Law Reform (Epidemic Preparedness) Bill, Second Reading, Hon PETE HODGSON (Minister of Health) 
283 R v Hansen [2007] 3 NZLR 1 (SC) the Supreme Court considered this provision and concluded that if the 
objective is sufficiently important and the means chosen to address the objective is proportional, such breaches 
are justified under the law. Being that the objective in this case is ensuring the public health of New Zealand it is 
likely that the means used in pursuit of this goal is the likely cause of debate and would be decided by the courts 
after the fact. 
284 National Health Committee, National Health Committee’s Advice on Living Cell Technologies Application for 
Xenotransplantation Clinical Trials in New Zealand, Ministry of Health, New Zealand, p. 18 
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Limits on Research 
 
This research was designed to track frame usage in the xenotransplantation debate, analyse 
the debate and discuss the process of the public engagement of science in the New Zealand 
context; it was not designed reveal the intentions of frame sponsors or to moralise frames. 
Nor, was this research designed to express an opinion on whether xenotransplantation is, or is 
not, an appropriate treatment for use within New Zealand. 
A further limit on this research is bias. Framing as a research method will continues to have 
on-going issues with bias due to human fallibility. As this research was done manually there 
will undoubtedly an element of inherent bias. This was mitigated by having a post-graduate 
student review every 15 pages of the dataset after receiving a tutorial in frame identification 
and when difference was noted this was discussed and a framing was either included, deleted 
depending on consensus before being added to the final frame table.285 
 
Contributions to the Biotechnology and Public Policy Debate 
 
This debate fits within the larger context of the public engagement of science and the current 
state of bioethics in New Zealand as it looks to distinguish itself in this area of science. The 
frequency and legitimacy of the public engagement of science is going to become increasing 
important. The social contract between science and society is still being negotiated as ideas of 
what public engagement of science means in terms of policy and regulation. 
                                                             
285It would have been interesting to note the difference as a point of investigation yet time restraints did not allow for 
this to occur in this particular research. 
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The groundswell of resistance to genetic modification in New Zealand, and the resistance to 
bio-banking in Iceland and Tonga serves as examples of the difficulties of practicing science 
without the public mandate. Institutions such as the RCGM and the Bioethics Council have 
been great vectors of communication, yet since the former fulfilled its mandate and the latter 
has been disestablished, the future of PES in New Zealand is uncertain. Despite this, the social 
contract between science and society continues to be negotiated, public debate on these issues 
will continue under increasing observation by the media and academia. 
Tracking the development of public debate in this area of biotechnology in New Zealand 
contributes to the understanding of how science as a field interacts with the public. Due to the 
reality that xenotransplantation presents a risk to third parties, the necessity of this 
interaction all the more apparent. For this reason, the public has a greater investment in the 
success or failure of this technology and therefore public's contributions should carry greater 
weight. This research presents a history and analysis of the public discussion that can serve as 
snapshot of New Zealand’s interaction with biotechnology and public policy formation. 
    
Prospects for Future Research 
 
The biotechnology industry in New Zealand has a strong global reputation that continues to 
invite both domestic and international investment. A strong biotechnology sector will produce 
many opportunities for the public engagement of science field. Living Cell Technologies is at 
the forefront of this development with plans to investigate Parkinson’s disease and 
Alzheimer’s disease. This direction is itself controversial in some respects, as deals with the 
brain, undoubtedly raising new issues of chimerism and identity. Other areas of research could 
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include the treatment of public submissions and cultural and ethical concerns since the 
disestablishment of the Bioethics Council.   
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Appendix B – Observed Frames and descriptions 
 
 
CODES DESCRIPTION 
  
Diagnostic frames This tells the frame audience what the 
issue and is and why it is significant. 
Government Interference Stated or suggested perceived 
governmental hindrance, filibustering and 
the expression of annoyance on the behalf of 
scientists, business leaders and potential 
benefactors of xenotransplantation. 
Government Alienation Expression of a perceived disconnect 
between the New Zealand Government and 
political process being described. E.g. Rubber 
stamp. 
Person vs. Public 
 
 
The direct comparison of personal benefit 
against public risk. 
131 
Problem Frame Outlines the problem that is being faced to 
which the solution is xenotransplantation. 
E.g. transplants, waiting lists, rates of 
diabetes. 
Risk-Medical Mentions of risk, risk assessments 
likelihood possible outcomes such as xenosis. 
Scandal Accusatory statements or inference about 
misdealing, being related to safety or ethical 
standards and potential or real illegality. 
Controversy The label attached to events, people, items 
or procedures e.g. controversial medical 
practice. 
Culture The presentation of concerns directly 
related to cultural interpretations of an issue 
or event. 
Runaway Science The reference to scientific progress being 
considered ‘out of control’, which is allowed 
through corrupt of ineffective regulation. 
Pioneer The direct reference to someone or 
something being a “pioneer” or “pioneering”. 
132 
Animal Rights A reference to the rights of the animal 
that is used in the xenotransplantation 
procedure. 
Bad Science An accusatory frame designed to 
undermine the credibility of a person or 
argument by referring to their work or 
reasoning as “bad science”. 
Pandora’s Box A reference to XTP as the Pandora’s Box 
archetype, out of which evil came out and 
was unable to be put back. 
Yuck A reference to the opinion that 
xenotransplantation is messy or disgusting. 
Uncertainty The reference to scientific knowledge 
bearing an element of uncertainty, mostly 
used in regards to risk. 
Extremist The reference to another party as being 
extremist in their views towards XTP. 
Guinea Pig The reference to patients undergoing 
xenotransplantation or the nation being test 
subjects for the pitfalls of XTP. 
133 
Liability A reference the issue of liability in the 
event of xenosis. 
Luddite An accusation of the other party being 
anti-progress. 
Public Consent The reference to the opinion that XTP is a 
collective risk that should result in collective 
consent from the New Zealand public. 
Chimera The reference to the chimera archetype or 
the description of xenotransplantation as 
being analogous. 
International A reference to xenotransplantation 
progress or regulation in a global context, 
usually applied in comparison to New 
Zealand. 
Natural Order The reference of a natural order that is 
being imbalanced by human interference. 
Prognostic Frame Presents a solution to the problem 
outlined by the diagnostic frame. 
Safeguard Reference to measures in place or taken to 
ensure public safety. E.g. mentions of 
regulation, precaution, banned, guidelines, 
134 
safeguard/s, independent or third party (in 
relation to oversight) and further research. 
Medical Ethics The reference of an issue or aspect of a 
procedure or process being of concern, 
interest or investigation from a medical 
ethics point of view. 
Not-A-Cure Used in reference to the idea that 
xenotransplantation of porcine islet cells into 
diabetics does not provide a cure for 
diabetes, but is a treatment. 
Rationality A call to face an issue rationally or to be 
rational. Generally used to undermine the 
opposing party. 
The Public Understanding of Science A reference to the need for, or efforts, to 
increase a greater public understanding of 
science, not a reference to the academic field.   
The Public Engagement of Science A reference to the need for, or efforts, to 
increase a greater level of public engagement 
with science, not a reference to the academic 
field. 
Alternative A reference to the idea that there are 
135 
alternatives to the medical concerns that 
xenotransplantation aims to treat. 
Grassroots A reference to the idea that 
xenotransplantation in New Zealand is a local 
operation that started from humble 
beginnings. 
Prevention A reference to the idea that 
xenotransplantation would not be needed if 
the public took greater care of their everyday 
health with healthy diet and exercise. 
Designer The reference to a scientist or scientists as 
being a designer in their manipulation of 
genetic material. 
Pharma-Pig The reference to the Auckland island pig 
population that had been geographically 
isolated for almost 200 years and later housed 
in medical standard piggeries in Invercargill. 
Personal responsibility The reference to the opinion that the risk 
of xenotransplantation as an issue to be 
discussed primarily between a doctor and 
patient. 
136 
Comparable The reference to xenotransplantation 
being a comparable to known medical 
technology or practice. 
International A reference to xenotransplantation 
progress or regulation in a global context, 
usually applied in comparison to New 
Zealand. 
Good-Guy-Scientist The reference of scientists having positive 
human elements such as ethics used to 
counter negative assumptions or associations 
about scientists.   
Motivational frame Offering a reason for people a reason to 
invest in xenotransplantation. 
Hope-Medical The presentation of expectations, hope or 
promise that regard the medical benefits of 
xenotransplantation. This includes other 
medical gains as a result of an expansion of 
biotechnology in New Zealand. 
Hope-Benefit The presentation of expectations, hope or 
promise regarding the potential gains to be 
had of xenotransplantation in New Zealand, 
including economic gains as a result of an 
137 
expansion of the biotechnology industry in 
New Zealand. 
Brand-State A reference to the idea that biotechnology 
could be incorporated into the national 
brand. 
Stewardship A cultural interpretation or reference to 
humans being stewards or bearing 
stewardship of nature, identity, genes. 
Southland Economic Hope A reference to the potential economic 
benefits to the Southland region of New 
Zealand as result of xenotransplantation, due 
to the specially made piggeries for housing 
the Auckland Island pig population used in 
Living Cell Technologies xenotransplantation 
procedures. 
Victim Focus on individual with diabetes or those 
on waiting lists, the main candidates for 
xenotransplantation technology in an effort 
to draw empathy. E.g. Diabetes suffering, 
viewpoints and hopes. 
 
138 
Future Generations The reference to children and 
grandchildren being possibly affected by the 
issue being discussed. 
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